Journal articles

Adams C, Conigrave J, Lewohl J, et al. Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis. Brain Behavior and Immunity 2020; 89:501–512.

Al-Ansari B, Noroozi A, Thow A, et al. Alcohol treatment systems in Muslim majority countries: Case study of alcohol treatment policy in Iran. International Journal of Drug Policy 2020; 80:102753.

Albuquerque PLMM, Paiva JHHGL, Martins AMC, et al. Clinical assessment and pathophysiology of Bothrops venom-related acute kidney injury: a scoping review. J Venom Anim Toxins Incl Trop Dis 2020: 26:e20190076.

Athavale A, Jamshidi N, Roberts DM. Anticipating an incomplete response to the recommended dose of idarucizumab. Clinical Toxicology 2020; 58(6):505–652.

Athavale A, Jamshidi N, Roberts DM. Quantifying the impact of acute and chronic kidney dysfunction on the effect of idarucizumab. Nephrology 2020; 25(Suppl. 3);40 – 82.

Athavale A, Jamshidi N, Roberts DM. Use for laboratory tests for identifying patients at risk of an incomplete response to the recommended dose of idarucizumab. Clinical Toxicology 2020; 58(6):505–652.

Bajis S, Grebely J, Hajarizadeh B, et al. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study. Journal of Viral Hepatitis 2020; 27(3):281–293.

Belackova V, Salmon AM, Jauncey M, Day CA. Safer injecting facilities-is the research there? A comment on Caulkins et al. (2020). Addiction 2020; 115(4):784–785.

Black E, Govindasamy L, Auld R, et al. Toxicological analysis of serious drug-related harm among electronic dance music festival attendees in New South Wales, Australia: A consecutive case series. Drug and Alcohol Dependence, 213, 108070.

Bravo M, Monds LA, Mills L, et al. The role of repeat training in participants undertaking take home naloxone interventions 2020. Preprinted in medRxiv; doi.org/10.1101/2020.04.26.20074542.

Brett J, Pearson SA, Daniels B, et al. A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy. Br J Clin Pharmacol 2020; 87(3):1369–1377.

Brown J, Berling I, Jiranantakan T, et al. Changing pattersn in deliberate self-poisonings from internet promotion: sodium nitrate. Clinical Toxicology 2020; 58(11):1104–1105.

Brown J, Buckley N, Cairns R, Wylie CE. Recognising injuries related to needlestick injury in farmers: the importance of identifying high pressure injections with mineral oil. Med J Aust 2020; 212(2):94–94e1.

Bruno C, Pearson S, Daniels B, et al. Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia. BMJ Quality and Safety 2020; 29(5):365–373.

Cairns R, Buckley N. After the deluge. The Australian Journal of Pharmacy 2020; 101(1193):34.

Chan B, Cheng S, Isoardi K, et al. Effect of age on the severity of chronic lithium poisoning. Clinical Toxicology 2020; 58(11):1023–1027.

Chan BS, Buckley, NA. Translating EXTRIP criteria to better define patients with lithium toxicity for haemodialysis. Br J Clin Pharmacol 2021; doi.org/10.1111/bcp.14567.

Cheng S, Buckley N, Siu, W, et al. Seasonal and temperature effect on serum lithium concentrations. Australian and New Zealand Journal of Psychiatry 2020; 54(3):282–287.

Chiew A, Reith D, Pomerleau A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust 2020; 212(4): 175–183.

Chiew AL, Buckley NA, Graudins A and Munir VL. Review article: Up (to) date for Australian Toxicology and Toxinology guidelines. Emergency Medicine Australasia 2021; 33(1):6-8.

Chitty KM, Schumann JL, Moran LL, et al. Reporting of alcohol as a contributor to death in Australian national suicide statistics and its relationship to post‐mortem alcohol concentrations. Addiction 2020; 116(3):506–513.

Chitty K, Schumann J, Schaffer A, et al. Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study. BMJ Open 2020; 10(5):e038181.

Chong D, Buckley N, Schumann J, Chitty K. Acute alcohol use in Australian coronial suicide cases, 2010-2015. Drug and Alcohol Dependence 2020; 212:108066.

Chung P, Logge WB, Riordan BC, et al. Genetic polymorphisms on OPRM1, DRD2, DRD4 and COMT in emerging adults: lack of association with alcohol consumption. Frontiers in Psychiatry 2020; 11:1429.

Conigrave JH, Harrison KH, Lee KSK, et al. Support can increase use of the AUDIT-C in Australian Aboriginal Community Controlled Health Services: a cluster randomised trial. Addiction 2020; 116(9):2304–2315.

Coupland H, Moensted ML, Reid S, et al. Developing a model of care for Substance Use in Pregnancy and Parenting Services, Sydney, Australia: Service provider perspectives. J Subst absue Treat 2021; 131:108420.

Crouse JJ, Morley KC, Buckley N, et al. Online interventions for people hospitalized for deliberate self-harm and problematic alcohol use: Lessons learned from the iiAIM trial. Bulletin of the Menninger Clinic 2021; 85(2):123-142.

Cullen H & Monds LA. Jury simulation studies: To exclude or not to exclude participants based on a lack of comprehension of the case? Applied Cognitive Psychology 2020; 34(5): 1224-1233.

Dale E, Conigrave KM, Kelly PJ, et al. A Delphi yarn: applying Indigenous knowledges to enhance the cultural utility of SMART Recovery Australia. Addict Sci Clin Pract 2021; 16(2).

Daniels B, Pearson S, Buckley NA, et al. Coming to grips with seemingly conflicting results in programme evaluation: the devil’s in the detail. BMJ Quality & Safety 2021; 30:70-71.

Daniels, B, Pearson, S-A, Vajdic et al. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study. Basic Clin Pharmacol Toxicol

2020; 127: 320– 328.

Daniels B, Pearson S, Buckley N, et al. Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016. Therapeutic Advances in Gastroenterology 2020; 13:1–11.

Dassanayake TL, Weerasinghe VS, Gawarammana I, Buckley NA. Subacute and chronic neuropsychological sequalae of acute organophosphate pesticide self-poisoning: a prospective cohort study from Sri Lanka. Clin Toxicol (Phila) 2020; 1–13.

Day C, White B, Reid S, et al. Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study. Australian and New Zealand Journal of Public Health 2020; 44(5): 360–362.

Day C, White N. Gender-Specific Online Content Is Important and Timely for Women Receiving Treatment for Substance Use Disorders. Journal of Women's Health 2020; 29(5): 605–606.

De Silva L, Dawson AH, Tennakoon S, et al. Life After non-fatal self-poisoning: a qualitative study on relationships and life circumstances after non-fatal self-poisoning. Clinical Toxicology 2020; 58(4):305.

Downs J, Lotan M, Elefant C, et al. Protocol: Implementing telehealth support to increase physical activity in girls and women with Rett syndrome-ActivRett: protocol for a waitlist randomised controlled trial. BMJ Open 2020; 10(12).

Doyle MP. Alcohol and drug research with Indigenous peoples: where do we go from here? Addiction 2020.

Doyle M, Guthrie J, Butler T, et al. Onset and trajectory of alcohol and other drug use among Aboriginal men entering a prison treatment program: A qualitative study. Drug and Alcohol Review 2020; 39(6):704–712.

Dunlop A, Lokuge B, Masters D, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal 2020; 17(1): 26.

Eastwood J, Barmaky S, Hansen S, et al. Refining Program Theory for a Place-Based Integrated Care Initiative in Sydney, Australia. International Journal of Integrated Care 2020; 20(3):13.

Eastwood JG, Dewhurst S, Hansen S, et al. Care Coordination for Vulnerable Families in the Sydney Local Health District: What Works for Whom, under What Circumstances, and Why? International Journal of Integrated Care 2020; 20(4):22.

Egunsola O, Buckley N, Raubenheimer JE. Price mark-up on the street sales of prescription pharmaceuticals in Australia. Journal of Substance Use 2020; 1–8.

Falster MO, Charrier R, Pearson S‐A, et al. Long‐term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol 2020; 1– 11.

Fisher A, Marel C, Morley K, et al. The role of alcohol and other drugs in suicidal behaviour and effective interventions to reduce suicidal thoughts and behaviours. Evidence check prepared for the National Suicide Prevention Task Force and commissioned through the Suicide Prevention Research Fund, Managed by Suicide Prevention Australia.

Flett JAM, Conner TS, Riordan BC, et al. App-based mindfulness meditation for psychological distress and adjustment to college in incoming university students: a pragmatic, randomised, waitlist-controlled trial. Psychol Health 2020; 35(9):1049-1074.

Giannopoulos V, Morley K, Uribe MG, et al. The role of clinical supervision in implementing evidence-based practise for managing comorbidity. The Clinical Supervisor, Special Issue on Clinical Supervision Research in Implementation Science, July 2021 in press.

Graham S, Mason A, Riordan BC, et al. Does taking a break from social media improve wellbeing? Cyberpsychology, Behavior, and Social Networking 2021.

Grimison P, Mersiades A, Kirby A, et al. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Annals of Oncology 2020; 31(11):1553–1560.

Haber PS, Kortt NC. Alcohol use disorder and the gut. Addiction 2020; 116(3):658–667.

Haghighi-Morad M, Naseri Z, Jamshidi N, et al. Methadone-induced encephalopathy: a case series and literature review. BMC Med Imaging 2020; 20(1):6.

Hamilton S, Maslen S, Watkins R, et al. "That thing in his head": Aboriginal and non-Aboriginal Australian caregiver responses to neurodevelopmental disability diagnoses. Sociology of Health & Illness 2020; 42(7):1581–1596.

Huang J, Buckley NA, Isoardi KZ, et al. Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning. Clin Toxicol (Phila) 2020; 1–8.

Hurzeler T, Giannopoulos V, Guajardo M, et al. Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials. Alcohol & Alcoholism 2020.

Isbister GK. Buckley N. Risks and realities of single vial antivenom recommendations for envenoming by Australian elapid snakes. Med J Aust 2020; 213(1): 45e1.

Isoardi K, Mudge D, Harris K, et al. Methamphetamine intoxication and acute kidney injury: A prospective observational case series. Nephrology 2020; 25(10):758–764.

James D, Lee K, Patrao T, et al. Understanding the client characteristics of Aboriginal residential alcohol and other drug rehabilitation services in New South Wales, Australia. Addiction Science & Clinical Practice 2020;15(1):27.

Jamshidi N, Athavale A, Murnion B. Buprenorphine not detected on routine urine drug screening in supervised treatment. Journal of Opioid management 2020.

Jamshidi N, Clark D, Murnion B. Recurrent Takotsubo cardiomyopathy associated with opioid withdrawal during Buprenorphine induction. Cardiovascualr toxicology 2021; doi: 10.1007/s12012-020-09624-z.

Jiang E, Raubenheimer JE, Ibister GK, et al. Machine read frontal QRS-T angle and QTc is no substitute for manual measurement of PTc in pro-arrhythmic drug overdose. Journal of Electrocardiology 2020; 65:151–156.

Kaye S, Lewandowski A, Bowman J, Doyle MF Crystal methamphetamine use among young people entering custody: Prevalence, correlates and comorbidity. Drug Alcohol Rev 2021.

Kirpich I, Warner D, Feng W, et al. Mechanisms, Biomarkers and Targets for Therapy in Alcohol-associated Liver Injury: From Genetics to Nutrition: Summary of the ISBRA 2018 Symposium. Alcohol 2020; 83:105–114.

Kloft L, Monds LA, Blokland A, et al. Hazy memories in the courtroom: a review of alcohol and other drug effects on false memory and suggestibility. Neuroscience & Biobehavioral Reviews 2021.

Kloft L, Otgaar H, Blokland A, et al. Cannabis Increases Susceptibility to False Memory. Proceedings of the National Academy of Sciences of the United States of America (PNAS) 2020; 117(9): 4585–4589.

Lee K, Fitts M, Conigrave J, et al. Recruiting a representative sample of urban South Australian Aboriginal adults for a survey on alcohol consumption. BMC Medical Research Methodology 2020; 20(1): 183.

Lees B, Squeglia L, McTeague L, et al. Altered Neurocognitive Functional Connectivity and Activation Patterns Underlie Psychopathology in Preadolescence, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2020; doi.org/10.1016/j.bpsc.2020.09.007.

Lees B, Stapinski L, Prior K, et al. Exploring the complex inter-relations between internalising symptoms, executive functioning and alcohol use in young adults. Addictive Behaviors 2020; 106:106351.

Lintzeris N, Monds L, Bravo M, et al. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives. Drug and Alcohol Review 2020; 39(1): 55-65.

Liu K, Verset G, Trepo E, Seth D. Genetics of alcohol-related hepatocellular carcinoma- its role in risk prediction. Hepatoma Research 2020; DOI: 10.20517/2394-5079.2020.25.

Louie E, Barrett E, Haber P, et al. A systematic review of evidence-based practice implementation in drug and alcohol settings: Applying the Consolidated Framework for Implementation Research Framework. Implementation Science 2020; 16:22.

Ly J, Brown JA, Buckley NA, et al. Paediatric poisoning exposures in schools: reports to Australia’s largest poisons centre. Archives of Disease in Childhood 2020; doi: 10.1136/archdischild-2020-319919.

Marel C, Mills K, Visontay R, et al. Australian treatment outcome study: protocol for the 18-20-year follow-up of a prospective longitudinal cohort examining the natural history of heroin dependence and associated mortality, psychiatric and physical health, and health service use. BMJ Open 2020; 10(7):e039226.

Mason A, Jang K, Morely K, et al. A content analysis of Reddit users’ reasons for not following through with a suicide attempt. Cyberpsychology, Behavior, and Social Networking 2020.

Moensted ML. Nearness and distance: the double-sided nature of belonging for young refugees in Australia, Social Identities 2020; 26(2): 270–285.

Moensted ML, Day CA. Operationalising cultural competency in the context of substance use treatment for Australian Muslims: A qualitative analysis. Drugs: Education, Prevention & Policy 2020; DOI: 10.1080/09687637.2021.1872501.

Moensted ML. Social Citizenship Aspirations: An Alternative Line of Analysis of the Social Reproduction of Youth Inequality. Young 2020;doi:10.1177/1103308820966437.

Moensted M, Day C. Health and social interventions in the context of support and control: The experiences of marginalised people who use drugs in Australia. Health and Social Care in the Community 2020; 28(4): 1152–1159.

Moensted ML. Examining Aspirational Horizons: Desirable and Achievable Futures for Disadvantaged Young People. JAYS 2020; 3:65–78.

Moensted ML, Day CA, Buus N. Youth Practitioners’ Perspectives on Building Agency and Supporting Transitions with and for Young People Experiencing Disadvantage. JAYS 2020; 3:293–310.

Monds LA, Cullen HJ, Kloft L, et al. Police perceptions of eyewitness impairment due to alcohol and other drug use: a cross-cultural comparison. PsyArXiv 2020.

Monds LA, Cullen HJ, Kloft L, et al. Memory and Credibility Perceptions of Alcohol and Other Drug Intoxicated Witnesses and Victims of Crime. PsyArXiv 2020.

Monds LA, Riordan B, Flett J, et al. How intoxicated are you? Investigating self and observer intoxication ratings in relation to BAC. Drug and Alcohol Reivew 2021.

Morley K, Lagopoulos J, Logge W, et al. Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study. Addiction Biology 2020; 25(1): e12702.

Morley K, Perry C, Watts J, et al. New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies. Expert Opinion in Pharmacotherapy 2021; DOI: 10.1080/14656566.2021.1892641.

Morley KC, Morris R, Logge W, et al. High dose baclofen administration attenuates insula response during anticipatory anxiety in alcohol dependent patients: preliminary results. European J neuropsych 2020.

Nielsen S, Sanfilippo P, Belackova V, et al. Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction 2020; doi: 10.1111/add.15297.

Egunsola O, Buckley NA, Raubenheimer JE. Price mark-up on the street sales of prescription pharmaceuticals in Australia. Journal of Substance Use 2020; DOI: 10.1080/14659891.2020.1851405.

Osna N, Ganesan M, Seth D, et al. Second hits exacerbate alcohol-related organ damage: an update, Alcohol and Alcoholism 2020; 56(1): 8–16.

Pai KG, Isoardi K, Buckely N, et al. Optimal way to achieve serum alkalinisation in tricyclic antidepressant overdose. Clinical Toxicology 2020; 58(6):618.

Pai KG, Isoardi K, Buckely N, et al. A Case series of flecainide poisoning. Clinical Toxicology 2020; 58(6): 618.

Pai KG, Isoardi K, Buckley N, et al. Effect of serum alkalinisation of QRS narrowing in tricyclc antidepressant poisoning. Clinical Toxicology 2020; 58(6):618.

Pathiraja V, Gawarammana I, Buckley N, et al. Clinical Toxicology 2020; 58(4):352–353.

Perananthan V, Mohamed F, Shahmy S et al. The clinical toxicity of imidacloprid self-poisoning following the introduction of newer formulations. Clin Toxicol (Phila) 2020; 22:1-4.

Perananthan V, Shores EA, Majumdar A, et al. Quality of life indicators in hepatic encephalopathy following supplementation with branched chain amino acids and/or synbiotics: A post‐hoc analysis. GastroHep 2020; 00: 1– 8.

Prior K, Salemink E, Wiers RW, et al. Acceptability and Co‐Development of an Online Cognitive Bias Modification Intervention for Emerging Adults With Hazardous Alcohol Use and Social Anxiety: A Mixed Methods Study. Alcohol Clin Exp Res 2020; 44: 2283–2297.

Purcell‑Khodr G, Lee K, Conigrave J, et al. What can primary care services do to help First Nations people with unhealthy alcohol use? A systematic review: Australia, New Zealand, USA and Canada. Addiction Science & Clinical Practice 2020; 15(1):31.

Raubenheimer J, Riordan B, Merrill J, et al. Hey Google! will New Zealand vote to legalise cannabis? Using Google Trends data to predict the outcome of the 2020 New Zealand cannabis referendum, International Journal of Drug Policy 2020; (90): 103083.

Reilly R, Wand H, McKetin R, et al. Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey. Drug and Alcohol Review 2020; 39(6): 646–655.

Riordan BC, Raubenheimer J, Ward RM, et al. Monitoring the sentiment of cannabis-related tweets in the lead up to New Zealand's cannabis referendum. Drug Alcohol Rev 2020; doi: 10.1111/dar.13184.

Riordan BC, Flett JAM, Cody L, et al. The Fear of Missing Out (FoMO) and event-specific drinking: The relationship between FoMO and alcohol use, harm, and Blood Alcohol Concentration during large social events. Current Psychology 2020.

Riordan B, Winter D, Day C, et al. What Are People Saying on Social Networking Sites About the Draft Australian Alcohol Consumption Guidelines? Medical Journal Australia 2020; 214(3).

Riordan BC, Cody L, Flett JAM, et al. The development of a single item FoMO (Fear of Missing Out) scale. Curr Psychol 2020; 39:1215–1220.

Roberts J, White B, Attalla D, et al. Rapid Upscale of Depot Buprenorphine (CAM2038) in Custodial Settings During the early covid‐19 pandemic in NSW, Australia. Addiction 2020.

Rombouts S, Conigrave J, Saitz R, et al. Evidence based models of care for the treatment of alcohol use disorder in primary health care settings: A systematic review. BMC Family Practice 2020; 21:260.

Roxburgh A, Jauncey M, Day CA, et al. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia. Harm Reduction Journal 2020; 18:20.

Scarf D, Riordan BC, Winter T. The association between New Zealand adolescents’ normative perceptions of pornography use and their frequency of pornography use. Medical Journal of New Zealand 2020; 133:1522.

Scarf D, Zimmerman H, Boden H, et al. A comparison of prejudice toward people with mental illness after viewing the films Joker or Terminator. JAMA Open 2020; 3(4):e203423.

Schaffer A, Cairns R, Brown J, et al. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine. Medical Journal of Australia 2020; 212(7): 321–327.

Schwantes‐An TH, Darlay R, Mathurin P, et al. Genome‐wide association study and meta‐analysis on alcohol‐related liver cirrhosis identifies novel genetic risk factors. Hepatology 2020.

Sehgal R, Kaur S, Shasthry S, et al. Natural Killer Cells contribute to pathogenesis of Severe Alcoholic Hepatitis by Inducing Lysis of Endothelial Progenitor Cells. Alcoholism: Clinical and Experimental Research 2020; 44(1): 78–86.

Seifert SA, Buckley N, Chan B, et al. Clinical Toxicology review metrics and expert reviewers. Clinical Toxicology 2020; 59(3): e1–3.

Shihana F, Barron ML, Mohamed F, et al. MicroRNAs in toxic acute kidney injury: Systematic scoping review of the current status. Pharmacology Research & Perspectives 2020; 9(2):e00695.

Shihana F, Joglekar M, Raubenheimer J, et al. Circulating human microRNA biomarkers of oxalic acid-induced acute kidney injury. Archives of Toxicology 2020; 94(5):1725–1737.

Shihana F, Mohamed F, Joglekar M, et al. Urinary versus serum microRNAs in human oxalic acid poisoning: Contrasting signals and performance. Toxicology Letters 2020; 334:21–26.

Stapinski LA, Sannibale C, Subotic M, et al. Randomised controlled trial of integrated cognitive behavioural treatment and motivational enhancement for comorbid social anxiety and alcohol use disorders. Australian & New Zealand Journal of Psychiatry 2020; doi:10.1177/0004867420952539

Sunderland M, Forbes M, Mewton L, et al. The structure of psychopathology and association with poor sleep, self-harm, suicidality, risky sexual behavior, and low self-esteem in a population sample of adolescents. Development and Psychopathology 2020; 1–12.

Surace A, Riordan BC. It could get better: A response to reports of Sexual Minorities’ life satisfaction in New Zealand. Australian and New Zealand Journal of Psychiatry 2020; 54(3): 322–323.

Tennant E, Miller E, Costantino K. et al. A critical realist evaluation of an integrated care project for vulnerable families in Sydney, Australia. BMC Health Serv Res 2020; 20:995.

Toscano R, Hudson JL, Baillie A J, et al. Development of the Macquarie Anxiety Behavioural Scale (MABS): a parent measure to assess anxiety in children and adolescents including young people with autism spectrum disorder. Journal of Affective Disorders 2020; 276:678-685.

Tremonti C, Volovets A, Jamshidi N, et al. Comment on pill testing review. Intern Med J 2020; 50(12):1596–1597.

Tulloch K, Baillie A. Development and Initial Evaluation of the Craving Metacognition Scale. Australian Psychologist 2020; 55(1):38-49.

Uribe Guajardo MG, Baillie A, Louie E, et al. Application of the Non-adoption, Abandonment, Scale-up, Spread and, Sustainability (NASSS) Framework to evaluate the role of technology in the Pathways to Comorbidity Care (PCC) implementation project to improve management of comorbid substance use and mental disorders. PsyArXiv 2020.

Vichitkunakorn P, Conigrave KM, Geater AF, et al. A Context-Specific Instrument to Record Drinking Behaviour: A Pilot Study on Implications of Identifying the Context of Risky Drinking. Community Ment Health J 2020.

Ward RM, Riordan BC, Merrill JE, Raubenheimer J. Describing the impact of the COVID‐19 pandemic on alcohol‐induced blackout tweets. Drug Alcohol Rev 2020.

Weatherall T, Conigrave K, Conigrave J, Lee K. What is the prevalence of current alcohol dependence and how is it measured for Indigenous people in Australia, New Zealand, Canada and the United States of America? A systematic review. Addiction Science & Clinical Practice 2020; 15(1):32.

Whitfield JB, Masson S, Liangpunsakul S, et al. Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers. American Journal of Gastroenterology 2021; 116(1): 106–115.

Wijerathna T, Mohamed F, Gawarammana IB, et al. Cellular injury leading to oxidative stress in acute poisoning with potassium permanganate/oxalic acid, paraquat, and glyphosate surfactant herbicide. Environmental Toxicology and Pharmacology 2020; 80: 1382–6689.

Winter T, Riordan BC, Pakpour AH, et al. Evaluation of the English Version of the Fear of COVID-19 Scale and Its Relationship with Behavior Change and Political Beliefs. Int J Ment Health Addiction 2020.

Winter DT, White N, Geiger B, et al. Should we be using e-vouchers to compensate research participants? Acceptability among opioid agonist treatment clients. Drug and Alcohol Review 2020.

Wong A, Yarema M, Isbister GK, et al. Comparison of adverse reactions to a 2 vs 3 bag IV acetylcysteine regimen during treatment of paracetamol overdose. Clinical Toxicology 2020; 58(4):326–327.

Wood K, Giannopolous V, Baillie A, et al. The role of clinical champions in facilitating the use of evidence-based practice in drug and alcohol and mental health settings: A systematic review. Implementation Research and Practice 2020.

Wylie C, Daniels B, Brett J, et al. A national study on prescribed medicine use in Australia on a typical day. Pharmacoepidemiology and Drug Safety 2020; 29(9):1046–1053.

Zamani N, Buckley N, Hassanian-Moghaddam H. Naloxone should remain the appropriate antidote to treat opioid overdose (reply). Critical Care 2020; 24:173.

Zheng D, Brett J, Daniels B, et al. Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014-2017). Drug and Alcohol Review 2020; 39(5):575–582.

Zimmerman H, Riordan BC, Winter T, et al. Neuroessentialism and mental illness stigma in psychology and non-psychology students. New Zealand Journal of Psychology 2020.

Ackermann D, Blyth F, Burgess A, Reid S. Rapid Evidence for Practice modules: using team-based learning to teach evidence-based medicine. International Journal of Epidemiology 2021; 50(Supp 1): dyab168.008.

Al Ansari M, Dawson A, Conigrave K. Alcohol: from Mesopotamia to Modern Iraq. J Ethn Subst Abuse 2021; 20(3): 343-365.

Al-Alansari F, et al. Health risks, preventive behaviours and respiratory illnesses at the 2019 Arbaeen: Implications for COVID-19 and other pandemics. Environmental Research and Public Health 2021; 18(6).

Baillie A, Marel C, Mills K, et al. Treatment for comorbidity. Guidelines For The Treatment of Alcohol Problems, Australian Government Department for Health and Aging, Chapter 10, 2021.

Barnett A, Savic M, Lintzeris N, et al. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia. Drug Alcohol Depend 2021; 227:108959.

Best D, et al. Justice Capital: A model for reconciling structural and agentic determinants of desistance. Probation Journal 2021; 68(2).

Brett J, Pearson SA, Daniels B, et al. A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy. Br J Clin Pharmacol 2021; 87(3): 1369–1377.

Bryant J, et al. Beyond deficit: strengths-based approaches in Indigenous health research. Sociology of Health & Fitness 2021.

Buckley NA, Fahim M, Raubenheimer J, et al. Case fatality of agricultural pesticides after self-poisoning in Sri Lanka: a prospective cohort study. Lancet Glob Health 2021; 9(6):e854–e862.

Chakraborty S, Jones M, Collie A, et al. Implementing work-related Mental health guidelines in general practice (IMPRovE): a protocol for a hybrid-III parallel cluster randomised controlled trial. Implementation Science 2021.16:77.

Chan BS, Buckley NA. Authors' reply to comment on: clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. Clin Toxicol (Phila) 2021; 1:doi:10.1080/15563650.2021.2013497

Chan, B. S., & Buckley, N. A. (2021). Translating EXTRIP criteria to better define patients with lithium toxicity for haemodialysis. Br J Clin Pharmacol, 87(4), 2157. doi:10.1111/bcp.14567

Chan BS, Isbister GK, Chiew A, et al. Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6). Clin Toxicol (Phila) 2021; 1-7: doi:10.1080/15563650.2021.1968422

Chan BS, Kiss A, McIntosh N, et al. E-cigarette or vaping product use-associated lung injury in an adolescent. Med J Aust 2021; 215(7):313–314.e311.

Chiew AL, Buckley NA. Acetaminophen Poisoning. Crit Care Clin 2021; 37(3): 543–561.

Chiew AL, Buckley NA, Graudins A, Munir VL. Review article: Up (to) date for Australian Toxicology and Toxinology guidelines. Emerg Med Australas 2021; 33(1): 6–8.

Chitty KM, Schumann JL, Moran LL, et al. Reporting of alcohol as a contributor to death in Australian national suicide statistics and its relationship to post-mortem alcohol concentrations. Addiction 2021; 116(3): 506–513.

Clapham K, et al. Digital support for Indigenous research methodologies. Australasian Journal of Information Systems 2021; 25.

Conigrave JH, et al. Alcohol consumption and dependence is linked to the extent that people experience need satisfaction while drinking alcohol in two Aboriginal and Torres Strait Islander communities. Addiction Science & Clinical Practise 2021; 16(1):1–11.

Conigrave JH, Conigrave KM, Wilson S, Lee KSK. Indigenous Australian drinking risk: Comparing risk categorisations based on recall of recent drinking occasions to AUDIT-C screening in a representative sample. Drug Alcohol Rev 2021: doi:10.1111/dar.13403

Conigrave JH, Harrison KH, Lee KSK et al. Support can increase use of the AUDIT-C in Australian Aboriginal Community Controlled Health Services: a cluster randomized trial. Addiction 2021; 116(9): 2304–2315.

Conigrave KM, Ali RL, Armstrong R, et al. Revision of the Australian guidelines to reduce health risks from drinking alcohol. Med J Aust 2021; 215(11):518–524.

Coupland H, Day C, Haber P, et al. Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study. Drug Alcohol Rev 2021; doi:10.1111/dar.13414.

Coupland H, Moensted ML, Reid S, et al. Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives. J Subst Abuse Treat 2021; 131: 108420.

Dale E, Conigrave KM, Kelly P J, et al. A Delphi yarn: applying Indigenous knowledges to enhance the cultural utility of SMART Recovery Australia. Addict Sci Clin Pract 2021; 16(1): 2.

Dale E, Lee KSK, Conigrave KM, et al. A multi-methods yarn about SMART Recovery: First insights from Australian Aboriginal facilitators and group members. Drug Alcohol Rev 2021; 40(6):1013–1027.

Daniels B, Pearson SA, Buckley NA, et al. Coming to grips with seemingly conflicting results in programme evaluation: the devil's in the detail. BMJ Qual Saf 2021; 30(1):70–71.

Dassanayake TL, Weerasinghe VS, Gawarammana IB, Buckley NA. Changes of attention-related brain activity over 6 months after acute organophosphate pesticide poisoning: a prospective follow-up study. Clin Toxicol (Phila) 2021; 1–9.

Day CA, et al. Providing appropriate treatment and care to people with alcohol problems: a summary for key specific populations. Medical Journal of Australia 2021; 215:S21–S27.

Donald JN, et al. Paths to the light and dark sides of human nature: A meta-analytic review of prosocial benefits of autonomy and the antisocial costs of control. Psychological Bulletin 2021; 147(9):921–946.

Doyle MF. Alcohol and drug research with Indigenous peoples: where do we go from here? Addiction 2021; 116(3):435–437.

Doyle MF, Williams M, Butler T, et al. Perspectives of prisoners on alcohol and other drug group treatment approaches. Int J Prison Health 2021; doi:10.1108/ijph-05-2021-0043

Dunlop AJ, White B, Roberts J, et al. Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Addiction 2022; 117(2):382–391.

Dzidowska M, et al. Support for Aboriginal health services in reducing harms from alcohol: 2-year service provision outcomes in a cluster randomized trial. Addiction 2021;117(3).

Ediriweera DS, Kasthuriratne A, Pathmeswaran A, et al. Evaluating spatiotemporal dynamics of snakebite in Sri Lanka: Monthly incidence mapping from a national representative survey sample. PLoS Negl Trop Dis 2021, 15(6), e0009447.

Falster MO, Charrier R, Pearson SA, et al. Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia. Br J Clin Pharmacol 2021; 87(3):1264–1274.

Farhoudian A, Radfar SR, Mohaddes Ardabili H, et al. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Front Psychiatry 2021; 12:646206.

Fernando K, Jayamanna S, Weerasinghe M, et al. Risk factors for deliberate self-harm in young people in rural Sri Lanka: a prospective cohort study of 22,000 individuals.

Fitts MS, Burchill R, Wilson S, et al. Drink driving among Aboriginal and Torres Strait Islander Australians: What has been done and where to next? Drug Alcohol Rev 2021; doi:10.1111/dar.13418.

Forbes MK, Sunderland M, Rapee RM, et al. A Detailed Hierarchical Model of Psychopathology: From Individual Symptoms up to the General Factor of Psychopathology. Clinical Psychological Science 2021; 9(2):139–168.

Freeburn B, et al. Coming of age: 21 years of opioid substitution treatment within an Aboriginal community-controlled primary health service Drug and Alcohol Review 2021.

Giannopoulos V, Morley K, Uribe G, et al. The role of clinical supervision in implementing evidence-based practice for managing comorbidity. The Clinical Supervisor 2021; 40(10):158-177.

Giannopolous V, Morley K, Haber P. How GPs can help detect and manage alcohol problems during the COVID-19 pandemic? Medicine Today 2021; 22(4):14–20.

Haber PS, Kortt NC. Alcohol use disorder and the gut. Addiction 2021; 116(3): 658–667.

Haber PS, Morley KC, Giannopoulos V. Alcohol–use and misuse during the COVID-19 pandemic, 2021.

Haber PS, Riordan BC, Morley KC. Treatment of alcohol problems: current status and future directions. Med J Aust 2021; 215(7):315–316.

Haber PS, Riordan BC, Winter DT, et al. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Medical Journal of Australia 2021; 215:S3-S32.

Hamilton SL, Maslen S. Redressing ‘unwinnable battles’: Towards institutional justice capital in Australian child protection. Journal of Sociology 2021: 14407833211010220.

Hamilton SL, et al. We don’t want you to come in and make a decision for us: Traversing cultural authority and responsive regulation in Australian child protection systems. Australian Journal of Social Issues 2021.

L Hides, BC Riordan, M Gullo et al. Caring for and managing patients with alcohol problems: interventions, treatments, relapse prevention, aftercare, and long term follow-up. Medical Journal of Australia 2021; 215(7):S12–S20.

Hurzeler T, Buckley NA, Noghrehchi F, et al. Alcohol-related suicide across Australia: a geospatial analysis. Aust N Z J Public Health 2021; 45(4):394–399.

Hurzeler T, Giannopoulos V, Uribe G, et al. Psychosocial Interventions for Reducing Suicidal Behaviour and Alcohol Consumption in Patients With Alcohol Problems: A Systematic Review of Randomized Controlled Trials. Alcohol 2021; 56(1):17-27.

James DB, Lee KSK, Dronavalli M, et al. Predictors of length of treatment, discharge reason, and re-admission to Aboriginal alcohol and other drug residential rehabilitation services in New South Wales, Australia. Drug Alcohol Rev 2021.

Jiang E, Raubenheimer JE, Isbister GK, et al. Machine read frontal QRS-T angle and QTc is no substitute for manual measurement of QTc in pro-arrhythmic drug overdose. J Electrocardiol 2021; 65:151–156.

Jiranantakan T, Brown J, Auld JA, et al. Surprise Illicit Substances-Lessons Learned From The Prescription, Recreational And Illicit Substance Evaluation Program In New South Wales. Drug and Alcohol Review 2021; 40S31–S32.

Kloft L, Monds LA, Blokland A, et al. Hazy memories in the courtroom: a review of alcohol and other drug effects on false memory and suggestibility. Neuroscience and Biobehavioral Reviews 2021; 124: 291–307.

Kaye S, Lewandowski A, Bowman J, Doyle MF. Crystal methamphetamine use among young people entering custody: Prevalence, correlates and comorbidity. Drug Alcohol Rev 2021; 40(7):1266–1274.

Lee KK, Conigrave JH, Al Ansari M, et al. Acceptability and feasibility of a computer-based application to help Aboriginal and Torres Strait Islander Australians describe their alcohol consumption. J Ethn Subst Abuse 2021; 20(1):16–33.

Lintzeris N, Dunlop AJ, Haber PS, et al. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial. JAMA Netw Open 2021; 4(5):e219041.

Logge WB, Morley KC, Haber PS. GABAB receptors and alcohol use disorders: clinical studies. Behavioral Neurobiology of GABAB Receptor Function 2021; 13:195-212.

Logge WB, Morris RW, Baillie AJ, et al. Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals. Psychopharmacology (Berl) 2021; 238(5):1291–1302.

Louie E, Barrett EL, Baillie A, et al. A systematic review of evidence-based practice implementation in drug and alcohol settings: applying the consolidated framework for implementation research framework. Implement Sci 2021; 16(1):22.

Louie E, Giannopoulos V, Baillie AJ, et al. Barriers and Facilitators to the Implementation of the Pathways to Comorbidity Care (PCC) Training Package for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings. Frontiers in Health Services 2021.

Louie E, Morley KC, Giannopoulos V, et al. Implementation of a Multi-Modal Training Program for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings: Pathways to Comorbidity Care (PCC). J Dual Diagn 2021; 17(4):304–312.

Marel C, Mills K, Stirling R, et al. Editorial. Advances in Dual Diagnosis 2021;14(1):1–7.

Mason A, Jang K, Morley K, et al. A Content Analysis of Reddit Users' Perspectives on Reasons for Not Following Through with a Suicide Attempt. Cyberpsychol Behav Soc Netw 2021; 24(10):642–647.

Mazza D, Chakraborty S, Camões-Costa V, et al. Implementing work-related mental health guidelines in general PRacticE (IMPRovE): a protocol for a hybrid III parallel cluster randomised controlled trial. Implementation Science 2021; 16(1):77.

McDonough M, Baillie AJ, Clark PJ et al. Caring for and managing patients with alcohol problems: interventions, treatments, relapse prevention, aftercare, and long term follow-up. Medical Journal of Australia 2021; 215(7): S28-S32.

Moensted ML, Buus N, Day CA. Examining facilitating relational dimensions of service encounters for disadvantaged people who use drugs. Journal of Addictions Nursing 2021.

Moensted ML, Day CA. Operationalising cultural competency in the context of substance use treatment for Australian Muslims: A qualitative analysis. Drugs: Education, Prevention & Policy 2021.

Monds LA, Riordan BC, Flett JAM, et al. How intoxicated are you? Investigating self and observer intoxication ratings in relation to blood alcohol concentration. Drug Alcohol Rev 2021; 40(7):1173–1177.

Morley KC. Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact. Addiction 2021; 116(11):3027–3028.

Morley KC, Logge WB, Fraser I, et al. High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study. Eur Neuropsychopharmacol 2021; 46:28–36.

Morley KC, Logge WB, Riordan BC, et al. Daily experiences of hangover severity and food consumption in young adults. Br J Health Psychol 2021.

Morley KC, Perry CJ, Watt J, et al. New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies. Expert Opin Pharmacother 2021; 22(10):1291–1303.

Morley KC, Rombouts S, Jamshidi N, Haber PS. Pharmacotherapies for alcohol dependence. Guidelines For The Treatment of Alcohol Problems, Australian Government Department for Health, Chapter 7, 2021.

Noroozi A, et al. Factors influencing engagement and utilisation of opium tincture-assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran. Drug and Alcohol Review 2021; 41(2).

O'Neill C, Najjar Z, Ingleton A, et al. Methaemoglobinaemia associated with the atypical use of sodium nitrite as a food additive. Med J Aust 2021; 215(6): 256–257.e251.

Osna NA, Ganesan M, Seth D, et al. Second hits exacerbate alcohol-related organ damage: an update. Alcohol Alcohol 2021; 56(1):8-16.

Perananthan V, Mohamed F, Shahmy S, et al. The clinical toxicity of imidacloprid self-poisoning following the introduction of newer formulations. Clin Toxicol (Phila) 2021; 59(4):347–350.

Perananthan V, Tremonti C, Nash E, et al. Rapid detection, toxicosurveillance and public health response to stimulant adulteration with acetyl fentanyl. Med J Aust 2021; 214(11):533–533.e531.

Prasadi GAM, Senarathna L, Dharmaratne SD. et al. Mothers’ ability to determine and measure paracetamol doses for children—a contrived observational study. Journal of Child Health Care 2021.

Prior K, Salemink E, Wiers RW, et al. A Web-Based Cognitive Bias Modification Intervention (Re-train Your Brain) for Emerging Adults With Co-occurring Social Anxiety and Hazardous Alcohol Use: Protocol for a Multiarm Randomized Controlled Pilot Trial. 2021; 10(7):e28667.

Pushpakumara P, Dawson A, Adikari A, et al. Exploration of associations between deliberate self-poisoning and psychiatric disorders in rural Sri Lanka: A case-control study. PloS one 2021; 16(8):e0255805.

Radfar SR, De Jong CAJ, Farhoudian A, et al. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Front Psychiatry 2021; 12:639393.

Raubenheimer JE, Riordan BC, Merrill JE, et al. Hey Google! will New Zealand vote to legalise cannabis? Using Google Trends data to predict the outcome of the 2020 New Zealand cannabis referendum. Int J Drug Policy 2021; 90:103083.

Riordan BC, Winter DT, Haber PS, et al. What are people saying on social networking sites about the Australian alcohol consumption guidelines? Med J Aust 2021; 214(3):105–107.e101.

Roberts DM, Hughes HK, Haber PS et al. Variability in insulin pharmacokinetics following high-dose insulin therapy. Clinical Toxicology 2021; 1–3.

Roberts J, White B, Attalla D et al. Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia. Addiction 2021; 116(2): 426-427.

Roxburgh A, Jauncey M, Day C, et al. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia. Harm Reduct J 2021; 18(1): 20.

Schaffer AL, Brett J, Buckley NA, Pearson SA. Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use. Pain 2021: doi:10.1097/j.pain.0000000000002433

Schwantes-An TH, Darlay R, Mathurin P, et al. Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors. Hepatology 2021; 73(5):1920–1931.

Seifert SA, Buckley N, Chan B, et al. Clinical Toxicology review metrics and expert reviewers, 2020. Clin Toxicol (Phila) 2021; 59(3):e1–e3.

Shihana F, Barron ML, Mohamed F, et al. MicroRNAs in toxic acute kidney injury: Systematic scoping review of the current status. Pharmacol Res Perspect 2021; 9(2):e00695.

Shihana F, Wong WKM, Joglekar MV, et al. Urinary microRNAs as non-invasive biomarkers for toxic acute kidney injury in humans. Sci Rep 2021; 11(1): 9165.

Siefried KJ, Ezard N, Christmass M, et al. A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia. Drug and Alcohol Review 2021; 41(2): 309–319.

Snijder M, et al. Strong and Deadly Futures: Co-Development of a Web-Based Wellbeing and Substance Use Prevention Program for Aboriginal and Torres Strait Islander and Non-Aboriginal Adolescents. International Journal of environmental research and public health 2021; 18(4):2176.

Stearne AE, et al. Identifying how the principles of self-determination could be applied to create effective alcohol policy for First Nations Australians: Synthesising the lessons from the development of general public policy. International Journal of Drug Policy 2021; 103260.

Subotic-Kerry M, Baillie A, Stapinski L, et al. The impact of alcohol use disorders and alcohol consumption on treatment-seeking individuals with social anxiety disorder. Bulletin of the Menninger Clinic 2021; 85(2):100-122.

Sullivan A, Ridley N, Monds LA, et al. Neuropsychological profiles on the Weschler Adult Intelligence Scale (WAIS-IV) of individuals attending a long-term residential rehabilitation program for substance use problems. Applied Neuropsychology: Adult 2021.

Suntai Z, White B. Social isolation among older veterans: findings from the National Health and Aging Trends Study. Aging Ment Health 2021;1–8.

Tong A, Sorrell T, Black A, et al. Research priorities for COVID-19 sensor technology. Nature Biotechnology 2021; 39(2):144–153.

Tran V, Reid SE, Roxburgh A, Day CA. Assessing Drug Consumption Rooms and Longer Term (5 Year) Impacts on Community and Clients. Risk Manag Healthc Policy 2021; 14:4639–4647.

Vichitkunakorn P, Conigrave KM, Geater AF, Assanangkornchai S. A Context-Specific Instrument to Record Drinking Behaviour: A Pilot Study on Implications of Identifying the Context of Risky Drinking. Community Ment Health J 2020; 57(1):167–177.

Watt J, Haber P, Conigrave K. Managing unhealthy alcohol use in general practice. Australian Doctor 2022; 13–20.

Weatherall TJ et al. Prevalence and correlates of alcohol dependence in an Australian Aboriginal and Torres Strait Islander representative sample: Using the Grog Survey App. Drug and Alcohol Review 2021.

Weatherall TJ, et al. Alcohol dependence in a community sample of Aboriginal and Torres Strait Islander Australians: harms, getting help and awareness of local treatments Addiction Science & Clinical Practise 2021; 16(1): 1–11.

Whitfield, J. B., Schwantes-An, T. H., Darlay, R., Aithal, G. P., Atkinson, S. R., Bataller, R.,et al., & GenomALC Consortium. (2022). A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. Journal of hepatology, 76(2), 275-282.

Whitfield JB, Schwantes-An TH, Darlay R et al. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatol. 2022; 76(2):275–282.

Wijewickrama ES, Mohamed F, Gawarammana IB, et al. Serum and urinary biomarkers for early detection of acute kidney injury following Hypnale spp. envenoming. PLoS Negl Trop Dis 2021; 15(12):e0010011.

Winter DT, Geiger B, Morley K, et al. Are bottle shops using Twitter to increase advertising or encourage drinking during COVID-19? Aust N Z J Public Health 2021; 45(4):391–393.

Winter DT, White N, Geiger B, et al. Should we be using e-vouchers to compensate research participants? Acceptability among opioid agonist treatment clients. Drug Alcohol Rev 2021; 40(7):1356–1357.

Zheng C, et al. Patterns of drinking in Aboriginal and Torres Strait Islander peoples as self‐reported on the Grog Survey App: A representative urban and remote sample Drug and Alcohol Review 2021.

Maddern XJ, Walker LC, Campbell EJ, Arunogiri S, Haber PS, Morley K, Manning V, Millan EZ, McNally GP, Lubman DI, Lawrence AJ. Can we enhance the clinical efficacy of cognitive and psychological approaches to treat substance use disorders through understanding their neurobiological mechanisms? Neurosci Biobehav Rev. 2022 Nov;142:104899. doi: 10.1016/j.neubiorev.2022.104899. Epub 2022 Sep 29. PMID: 36183863

Whitfield JB, Morgan TR, Seth D. Reply to: "External validation of a genetic risk score that predicts development of alcohol-related cirrhosis". J Hepatol. 2022 Dec;77(6):1721-1722. doi: 10.1016/j.jhep.2022.08.024. Epub 2022 Aug 31. PMID: 36055430.

Moensted ML, Buus N, Day CA. Examining Relational Dimensions of Service Encounters for Disadvantaged People Who Use Drugs. J Addict Nurs. 2022 Jul-Sep 01;33(3):159-167. doi: 10.1097/JAN.0000000000000479. PMID: 36041158.

Coupland H, Day C, Haber P et al. Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study. Drug and Alcohol Review (March 2022), 41, 706–714

Liu K, Terry Y, Masson S, Fateen W, Schwantes-An T-H, McCaughan GW, Aithal G, Seth D. Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol-related cirrhosis patients. Liver Cancer International 2022, 3: 99-104.

Whitfield JB, Seth D, Morgan TR. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank. Alcohol Clin Exp Res 2022, 46(12):2245-2257. DOI: 10.1111/acer.14968.

Whitfield JB, Schwantes-An T-H, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet J-M, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Mullhaupt B, Nagy L, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trepo E, Morgan TR, Seth D: A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers. J Hepatology 2022, 76(2):275-82.

Isbister GK, Jenkins S, Noutsos T, Isoardi KZ, Soderstrom J, Buckley NA. The diagnostic value of D-Dimer in Australian snake envenoming (ASP-29). Medical Journal of Australia 2022;217(4):203-7. doi: 10.5694/mja2.51589.

Noghrehchi F, Raubenheimer J, Dawson AH Buckley NA. Role of age-sex as underlying risk factors for death in acute pesticide self-poisoning: A prospective cohort study. Clinical Toxicology 2022;60(2):184-190. doi: 10.1080/15563650.2021.1921186

Wijerathna TM, Buckley NA, Gawarammana IB, Raubenheimer J, Shahmy S, Chathuranga U, Palangasinghe C, Shihana F, Dissanayake AMSDM, Mohamed F. Epidemiology and renal injury following Methyl-4-chlorophenoxyacetic acid (MCPA) poisoning. Scientific Reports 2022; 12:21940. doi: 10.1038/s41598-022-25313-z.

Chitty KM, Raubenheimer J, Kirby K, Cairns R, Buckley NA. Deliberate self-poisoning in Australian adolescents is increased on school days. Journal of Psychiatric Research 2022; 148: 103–109. doi: 10.1016/j.jpsychires.2022.01.045

Perananthan V, Wijerathna TM, Mohamed F, Gawarammana IB, Dawson AH, Buckley NA. Circulating intestinal fatty acid binding protein and gastrointestinal toxicity in Russell’s Viper envenomation. Clinical Toxicology 2022;60(3):311-318. doi:10.1080/15563650.2021.1965160.

Schaffer A, Bruno C, Buckley NA, Cairns R, Litchfield M, Paget S, Zoega H, Nassar N, Pearson SA. Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children. Paediatric and Perinatal Epidemiology 2022; 36:726–737. doi:10.1111/ppe.12870.

Daniels B, Schaffer A, Buckley NA, Bruno C, Jun M, Pearson SA, Zoega H. The impact of new prescribing restrictions for proton pump inhibitors in Australia: an evaluation using interrupted time series analysis. Pharmacoepidemiology and Drug Safety 2022;31(3):370-378. doi: 10.1002/pds.5395.

Nendick E, Mohamed F, Raubenheimer J, Gawarammana I, Buckley NA, Eddleston M. Acute Fungicide Self-Poisoning - A Prospective Case Series. Clinical Toxicology 2022;60(10):1106-12. doi: 10.1080/15563650.2022.2105710.

Dassanayake TL, Weerasinghe VS, Gawarammana I, Cooper P, Buckley NA. Changes of attention-related brain activity over 6 months after acute organophosphate pesticide poisoning: a prospective follow-up study. Clinical Toxicology 2022; 60(5): 576-584. doi: 10.1080/15563650.2021.2010742.

Schaffer AL, Brett J, Buckley NA, Pearson SA. Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use. Pain 2022; 163: e614–e621. doi:10.1097/j.pain.0000000000002433.

Chan BS, Isbister GK, Chiew AL, Isoardi K, Buckley NA. Clinical Experience with Titrating Doses of Digoxin Antibodies in Acute Digoxin Poisoning (ATOM-6). Clinical Toxicology 2022; 60(4):433-439. doi: 10.1080/15563650.2021.1968422.

Chiew AL, Raubenheimer JE, Berling I, Buckley NA, Becker T, Chan B, Brett J. Just “nanging” around - nitrous oxide abuse. A retrospective case series and review of internet searches, social media posts and the coroner’s database. Internal Medicine Journal 2022;52: 1724–1732. doi: 10.1111/imj.15391

Pai K, Buckley NA, Isoardi KZ, Isbister GK, Becker T, Chiew AL, Cairns R, Brown J, Chan BS. Optimising Alkalinisation and its effect on QRS Narrowing in Tricyclic Antidepressant Poisoning. British Journal of Clinical Pharmacology 2022;88:723–733. doi: 10.1111/bcp.15008

Rambabu L, Mohamed F, Raubenheimer J, Roberts MS, Buckley NA, MacKenzie L, Gawarammana IB, Eddleston M. Acute phenthoate self-poisoning: a prospective case series. Clinical Toxicology 2022;60(2):214-220. doi: 10.1080/15563650.2021.1917596

Rahman S, Trussell A, Pearson SA, Buckley NA, Karanges EA, Cairns R, Litchfield M, Todd A, Gisev N. Trends in fentanyl utilisation and fatal overdose across Australia, 2003-2015. Drug and Alcohol Review 2022;41(2):435-443. doi:10.1111/dar.13391.

Mirabella J, Ravi D, Chiew A, Buckley NA, Chan BS. Prescribing Trend of Tapentadol in a Sydney Local Health District. British Journal of Clinical Pharmacology 2022; 88:3929–3935. doi: 10.1111/bcp.15448.

Chiew AL, Buckley NA. The Serotonin Toxidrome: shortfalls of current diagnostic criteria for related syndromes. Clinical Toxicology 2022;60(2):143-158. doi: 10.1080/15563650.2021.1993242.

Ling R, White B, Roberts J, Cretikos M, Howard MV, Haber PS, Lintzeris N, Reeves P, Dunlop AJ, Searles A. Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model. BMC Health Serv Res. 2022 Nov 8;22(1):1326. doi: 10.1186/s12913-022-08687-8.

Merrick TT, Louie E, Cleary M, Molloy L, Baillie A, Haber P, Morley KC. A systematic review of the perceptions and attitudes of mental health nurses towards alcohol and other drug use in mental health clients. Int J Ment Health Nurs. 2022 Dec;31(6):1373-1389. doi: 10.1111/inm.13043. Epub 2022 Jul 31. PMID: 35909095

Louie E, Giannopoulos V, Baillie A, Uribe G, Wood K, Teesson M, Haber PS, Morley KC. Relationship between clinician-level attributes and implementation outcomes from the Pathways to Comorbidity Care training program. BMC Med Educ. 2022 Aug 5;22(1):605. doi: 10.1186/s12909-022-03671-6. PMID: 35931994

Chitty KM, Cvejic RC, Heintze T, Srasuebkul P, Morley K, Dawson A, Carter G, Dinh M, Buckley NA, Trollor JN. The Association Between Problematic Use of Alcohol and Drugs and Repeat Self-Harm and Suicidal Ideation. Crisis. 2022 Sep 8. doi: 10.1027/0227-5910/a000880. Epub ahead of print. PMID: 36073254.

Louie E, Giannopoulos V, Uribe G, Wood K, Teesson M, Childs S, Baillie A, Haber PS, Morley KC. Geographical variation in implementation of the Pathways to Comorbidity Care program in Australian drug and alcohol services. JBI Evid Implement. 2022 Oct 5. doi: 10.1097/XEB.0000000000000344. Epub ahead of print. PMID: 36378096.

Uribe Guajardo MG, Baillie A, Louie E, Giannopoulos V, Wood K, Riordan B, Haber P, Morley K. The evaluation of the role of technology in the pathways to comorbidity care implementation project to improve management of comorbid substance use and mental disorders. J Multimorb Comorb. 2022 Apr doi: 10.1177/26335565221096977. PMID: 35586033;

Josifovski N, Shand F, Morley K, Chia J, Henshaw R, Petrie K, Reda B, Li E, Theobald A, Onie S, Torok M, Berrouiguet S, Batterham PJ, Carter G, Haber P, Christensen H, Larsen ME. A pilot study of a text message and online brief contact intervention following self-harm or a suicide attempt: A mixed methods evaluation. Gen Hosp Psychiatry. 2022 May-Jun;76:1-2. doi: 10.1016/j.genhosppsych.2022.03.002. Epub 2022 Mar 11. PMID: 35303519.

Morley KC, Louie E, Hurzeler T, Baillie A, Dore G, Phung N, Haber PS. Sex as a Potential Moderator for Baclofen Response in the Treatment of Alcohol Dependence. Front Glob Womens Health. 2022 Mar 29;3:807269. doi: 10.3389/fgwh.2022.807269. PMID: 35425938

Louie E, Giannopoulos V, Baillie A, Uribe G, Wood K, Teesson M, Childs S, Rogers D, Haber PS, Morley KC. Barriers and Facilitators to the Implementation of the Pathways to Comorbidity Care (PCC) Training Package for the Management of Comorbid Mental Disorders in Drug and Alcohol Settings Frontiers in Health Services: Implementation Science, 17(4):304-312

Morley KC, Logge WB, Riordan BC, Brannon S, Haber PS, Conner TS. Daily experiences of hangover severity and food consumption in young adults. Br J Health Psychol. 2022 May;27(2):468-483. doi: 10.1111/bjhp.12555. Epub 2021 Aug. PMID: 34431182

Logge W, Baillie A, Haber P, Towers E, Riordan BC, Morley K. Sex differences in the interrelations between stress, craving and alcohol consumption across individuals and time during baclofen treatment for alcohol dependence. Addict Behav. 2023 Jan;136:107462. doi: 10.1016/j.addbeh.2022.107462. Epub 2022 Aug 11. PMID: 36084413.

Purcell-Khodr G, Webster E, Harrison K, Dawson A, Lee K, Conigrave K. The Importance of Culture in Alcohol Care: Listening to First Nations staff in Australian Aboriginal Community Controlled Health Services. The International Indigenous Policy Journal. 2022;13(3):1-29.

Lee K, Bullen LM, Zheng C, Dawson A, Munro A, Conigrave KM. Beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal clients to involuntary drug and alcohol treatment: A qualitative study. Drug and Alcohol Review. 2023;42(1):169-80. (First published 04 October 2022)

Stearne AE, Lee K, Allsop S, Shakeshaft A, Wright M. Self-determination by First Nations Australians in alcohol policy: lessons from Mbantua/Alice Springs (Northern Territory, Australia). International Journal of Drug Policy. 2022;108:103822.

Lee K, Wilson S, Stearne AE, Hayman N, Conigrave JH, Doyle M, Bullen L, Weatherall TJ, James D, Reynolds T, Perry J. Walking side‐by‐side: Supporting Aboriginal and Torres Strait Islander Australians to lead the way in alcohol research. Drug and Alcohol Review. 2023;42(2):241-7. (first published 04 August 2022)

Conigrave JH, Lee K, Haber PS, Vnuk J, Doyle MF, Conigrave KM. More than three times as many Indigenous Australian clients at risk from drinking could be supported if clinicians used AUDIT-C instead of unstructured assessments. Addiction Science & Clinical Practice. 2022;17(1):23.

Dzidowska M, Raubenheimer JE, Dobbins TA, Lee K, Hayman N, Vnuk J, Haber P, Conigrave KM. Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial. Addiction science & clinical practice. 2022;17(1):1-2.

Routledge K, Snijder M, Newton N, Ward J, Doyle M, Chapman C, Champion KE, Lees B, Bock SG, Wang Y, Olthuis PW. Acceptability and feasibility of Strong & Deadly Futures, a culturally-inclusive alcohol and drug prevention program for Aboriginal and/or Torres Strait Islander secondary students. SSM-Mental Health. 2022;2:100073.

Stearne AE, Lee K, Allsop S, Shakeshaft A, Wright M. First Nations Australians’ self-determination in health and alcohol policy development: a Delphi study. Health Research Policy and Systems. 2022;20(1):12.

Stapinski L, Routledge K, Snijder M, Doyle M, Champion K, Chapman C, Ward J, Baumgart A, Lee K, Teesson M, Newton N. A web-based alcohol and other drug prevention program (Strong & Deadly Futures) for Aboriginal and Torres Strait Islander school students: protocol for a cluster randomized controlled trial. JMIR Research Protocols. 2022;11(1):e34530.

Conigrave JH, Wilson S, Conigrave KM, Chikritzhs T, Hayman N, Dawson A, Ali R, Perry J, Fitts MS, Degenhardt L, Doyle M, Lee K. ‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians. Addiction Science & Clinical Practice. 2022;17(1):1-1.

Gendera S, Treloar C, Reilly R, Conigrave KM, Butt J, Roe Y, Ward J. ‘Even though you hate everything that's going on, you know they are safer at home’: The role of Aboriginal and Torres Strait Islander families in methamphetamine use harm reduction and their own support needs. Drug and Alcohol Review. 2022;41(6):1428-39.

Noroozi A, Conigrave KM, Mirrahimi B, Bastani P, Charkhgard N, Salehi M, Narenjiha H, Vaziri A, Kebriaeezadeh A. Factors influencing engagement and utilisation of opium tincture‐assisted treatment for opioid use disorder: A qualitative study in Tehran, Iran. Drug and Alcohol Review. 2022;41(2):419-29.

Doyle MF, Guthrie J, Butler T, Shakeshaft A, Conigrave K, Williams M. Opportunities for intervention for alcohol and other drug use problems for men before prison: A qualitative study. Health Promotion Journal of Australia. 2022.

Al Ansari M, Dawson A, Conigrave K. Alcohol among young people in Iraq: a systematic scoping review. Discover Psychology. 2022;2(1):16.

Conigrave JH, Conigrave KM, Wilson S, Lee K. Indigenous Australian drinking risk: Comparing risk categorisations based on recall of recent drinking occasions to AUDIT‐C screening in a representative sample. Drug and Alcohol Review. 2022;41(3):616-24.

Doyle MF, Williams M, Butler T, Shakeshaft A, Conigrave K, Guthrie J. Perspectives of prisoners on alcohol and other drug group treatment approaches. International Journal of Prisoner Health. 2022;18(1):55-65.

Al Ansari M, Dawson A, Room R, Abdulzahra M, Conigrave KM. Alcohol and University Students in Iraq: Attitudes, Availability, and Use. Journal of Muslim Mental Health. 2022;16(2).

Zheng C, Conigrave JH, Conigrave KM, Wilson S, Perry J, Chikritzhs TN, Fitts MS, Lee K. Patterns of drinking in Aboriginal and Torres Strait Islander peoples as self‐reported on the Grog Survey App: a representative urban and remote sample. Drug and Alcohol Review. 2022;41(1):114-24.

Weatherall TJ, Conigrave JH, Conigrave KM, Perry J, Wilson S, Room R, Fitts MS, Hayman N, Lee K. Prevalence and correlates of alcohol dependence in an Australian Aboriginal and Torres Strait Islander representative sample: using the Grog Survey App. Drug and Alcohol Review. 2022;41(1):125-34.

Bradshaw EL, Conigrave JH, Steward BA, Ferber KA, Parker PD, Ryan RM. A meta-analysis of the dark side of the American dream: Evidence for the universal wellness costs of prioritizing extrinsic over intrinsic goals. Journal of Personality and Social Psychology. 2022.

James DB, Lee K, Dronavalli M, Courtney RJ, Conigrave KM, Conigrave JH, Shakeshaft A. Predictors of length of treatment, discharge reason, and re‐admission to Aboriginal alcohol and other drug residential rehabilitation services in New South Wales, Australia. Drug and Alcohol Review. 2022;41(3):603-15. doi: 10.1111/dar.13388. Epub 2021 Oct 13. PMID: 34644427.

Dunlop AJ, White B, Roberts J, Cretikos M, Attalla D, Ling R, Searles A, Mackson J, Doyle MF, McEntyre E, Attia J. Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Addiction. 2022;117(2):382-91.

Lee K, Wilson S, Stearne A, Hayman N, Conigrave JH, Doyle MF, Bullen L, Weatherall TJ, James Douglas B, Reynolds T, Perry J, Conigrave KM. Walking side-by-side: supporting Aboriginal and Torres Strait Islander Australians to lead the way in alcohol research. Drug Alcohol Rev. 2022;doi.org/10.1111/dar.13523

Doyle MF, Dsouza B, Conigrave KM. Perceived impacts of a prison-based drug treatment program on planning for release: A qualitative study. Drug and Alcohol Review. 2022; 41:S18.

Freeburn B, Loggins S, Lee K, Conigrave K. Coming of age: 21 years of providing opioid substitution treatment within an Aboriginal community-controlled primary health service. Drug Alcohol Rev. 2022;41(1):260-4.

Dzidowska M, Lee K, Conigrave JH, Dobbins TA, Hummerston B, Wilson S, Haber PS, Gray D, Conigrave KM. Support for Aboriginal health services in reducing harms from alcohol: 2-year service provision outcomes in a cluster randomized trial. Addiction [Internet]. 2022;117(3):796-803.

Watt J, Haber P, Conigrave K. How to Treat: Unhealthy alcohol use. Australian Doctor. 2022;13-20.

Qiang S, Mohamed F, Mackenzie L, Roberts MS. Rapid determination of polyethoxylated tallow amine surfactants in human plasma by LC-MSMS. Talanta. 2022 Nov 19;254:124115. doi: 10.1016/j.talanta.2022.124115. Epub ahead of print. PMID: 36481395.

Deuster E, Tomenson JA, Mohamed F, Gawarammana I, Buckley NA, Wilks MF, Eddleston M. Dose ingested, vomiting, and outcome in patients ingesting a standard paraquat 20SL formulation. Clinical Toxicology. 2022 Dec 21:1-10. doi: 10.1080/15563650.2022.2142601. Epub ahead of print. PMID: 36541442.

Dhanarisi J, Perera S, Wijertahna T, Gawarammana I, Eddleston M, Mohamed F. Relationship between alcohol co-ingestion and clinical outcome in pesticide self-poisoning: a systematic review and a meta-analysis. Alcohol and Alcoholism, 2022; agac045

Schölin L, Weerasinghe M, Agampodi S, Chathurange U, Rajapaksha S, Holloway A, Norrie J, Mohamed F, Eddleston M, Pearson M. (March 2022) Involvement of alcohol in injury cases in rural Sri Lanka: prevalence and associated factors among in-patients in three primary care hospitals. BMC Public Health, 22(1)

Egan L, Riordan B, Newling G, Uthurralt N., Day, CA. (2022) Sydney’s inner-west is brimming with micro-breweries, should we be worried and what does it mean for research and policy? Drug and Alcohol Review. DOI: 10.1111/dar.13611

Day CA, Salmon A, Jauncey M, Bartlett M, Roxburgh A. (2022) Twenty years at the Uniting Medically Supervised Injecting Centre, Sydney Australia: addressing the remaining questions. Medical Journal of Australia, 271(8): 385-387 DOI:10.5694/mja2.51716

Reid SE, Day CA, White N, Harrison, C, Haber PS, Bayram C. (2022) Patterns of opioid prescribing in Australian General Practice. BMC Primary Care; 23: 171. https://doi.org/10.1186/s12875-022-01783-y

Coupland H, Henderson C, Pritchard-Jones, J, Kao, S, Sheils S, Nagy R, O’Donnell M, Haber, PS, Day CA. (2022) “Setting foot in private spaces: Extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines. BMC Harm Reduction Journal; 19:56. doi.org/10.1186/s12954-022-00640-6

Uthurralt, N, McGlinn, A, O’Donnell, M, Haber, PS. Day, CA. (2022). The impact of 24-hour syringe dispensing machine on use of face-to-face needle and syringe program and targeted primary healthcare clinic for people who inject drugs. Australian and New Zealand Journal of Public Health, 46(4): 524-526. http://doi.org/10.1111/1753-6405.13267

Winter DT, Geiger B, Day, CA. (2022) A comment on participant reimbursement within Australian drug and alcohol research. Drug and Alcohol Review. 41: 1484-1486 https://doi.org/10.1111/dar.13452

Coupland H, Haber P, Day CA, Pritchard-Jones J, McKee K, George J, McCaughan G. (2022) “It’s another thing to deal with”: Resisting hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia. Drug and Alcohol Review. DOI: 10.1111/dar.13414

Logge WB, Morley KC, Haber PS. GABAB Receptors and Alcohol Use Disorders: Clinical Studies. Curr Top Behav Neurosci. 2022;52:195-212. doi:10.1007/7854_2020_182. PMID: 33580440.

Evans NT, Williams N, Perananthan V, Lugg W, Dawson AH, Osborn DA. Neonatal serotonin toxicity. J Paediatr Child Health. 2022 Jan;58(1):189-190. doi: 10.1111/jpc.15443. Epub 2021 Mar 16. PMID: 33724598

Fitts MS, Burchill R, Wilson S, Palk GR, Clough AR, Conigrave KM, Slade T, Shakeshaft A, Lee KSK. Drink driving among Aboriginal and Torres Strait Islander Australians: What has been done and where to next? Drug Alcohol Rev. 2022 Sep;41(6):1412-1417. doi: 10.1111/dar.13418. Epub 2021 Dec 19. PMID: 34927302

Smith JL, Soderstrom J, Dawson A, Alfred S, Greene S, Isoardi K, McCutcheon D, Oosthuizen F, Ezard N, Burcham J, Fatovich DM; EDNA Investigators. The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department. Emerg Med Australas. 2022 Feb;34(1):58-64. doi: 10.1111/1742-6723.13839. Epub 2021 Aug 12. PMID: 34382338.

Siefried KJ, Ezard N, Christmass M, Haber P, Ali R; NCCRED Methamphetamine and Emerging Drugs Clinical Research Network Working Group. A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia. Drug Alcohol Rev. 2022 Feb;41(2):309-319. doi: 10.1111/dar.13350. Epub 2021 Jul 8. PMID: 34237176

Sahinovic A, Irwin C, Doohan PT, Kevin RC, Cox AJ, Lau NS, Desbrow B, Johnson NA, Sabag A, Hislop M, Haber PS, McGregor IS, McCartney D. Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial. Sports Med Open. 2022 Mar 2;8(1):27. doi:10.1186/s40798-022-00417-y. PMID: 35235092; PMCID: PMC8891421.

Graham S, Blaxland M, Bolt R, Beadman M, Gardner K, Martin K, Doyle M, Beetson K, Murphy D, Bell S, Newman CE, Bryant J. Aboriginal peoples’ perspectives about COVID-19 vaccines and motivations to seek vaccination: a qualitative study. BMJ Glob Health. 2022 Jul;7(7):e008815. doi:10.1136/bmjgh-2022-008815. PMID: 35858705; PMCID: PMC9304971.

Nash E, Walker E, Watt J, Sannikova A, Dawson A, Anderson T, Sheather M, Jewitt J, Linnegar P, Hutchings O, Haber PS. Management of alcohol and other drug issues in Special Health Accommodation during the COVID-19 Delta variant outbreak in Sydney, 2021. Drug Alcohol Rev. 2022 Sep;41(6):1319-1321. doi:10.1111/dar.13506. Epub 2022 Jun 21. PMID: 35730108

Dawson A. Physostigmine should be used more readily for antimuscarinic toxicity: PRO. Br J Clin Pharmacol. 2022 Jan;88(1):58-60. doi:10.1111/bcp.15120. Epub 2021 Nov 16. PMID: 34705298

Chan BS, Sheppeard V, Dawson AH. E-cigarette or vaping product use-associated lung injury in an adolescent. Med J Aust. 2022 Apr 18;216(7):374.doi: 10.5694/mja2.51473. Epub 2022 Mar 24. PMID: 35324022

Graham S, Martin K, Beadman M, Doyle M, Bolt R. Our relationships, our values, our culture - Aboriginal young men's perspectives about sex, relationships and gender stereotypes in Australia. Cult Health Sex. 2023 Mar;25(3):304-319. doi: 10.1080/13691058.2022.2039776. Epub 2022 Feb 22. PMID: 35192437.

Isbister GK, Noutsos T, Jenkins S, Isoardi KZ, Soderstrom J, Buckley NA. D-dimer testing for early detection of venom-induced consumption coagulopathy after snakebite in Australia (ASP-29). Med J Aust. 2022 Aug 15;217(4):203-207. doi: 10.5694/mja2.51589. Epub 2022 Jun 7. PMID: 35670073.

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2023 Feb 20;218(3):138-139. doi: 10.5694/mja2.51797. Epub 2022 Dec 1. PMID: 36453811

Rafizadeh A, Bhalla A, Sharma N, Kumar K, Zamani N, McDonald R, Roberts DM, Hassanian-Moghaddam H. Evaluating new simplified assays for harm reduction from methanol poisoning using chromotropic acid kits: An analytical study on Indian and Iranian alcoholic beverages. Front Public Health. 2022;10: 983663.

Ghannoum M, Roberts DM, Goldfarb DS, Heldrup J, Anseeuw K, Galvao TF, Nolin TD, Hoffman B, Lavergne V, Meyers P, Gosselin S, Botnaru T, Mardini K, Wood DM. Extracorporeal treatment for methotrexate poisoning: Systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Neph 2022; 17(4): 602-622

Bouchard J, Yates C, Calello DP, Gosselin S, Roberts DM, Lavergne V, Hoffman RS, Ostermann M, Peng A, Ghannoum M; EXTRIP Workgroup. Extracorporeal Treatment for Gabapentin and Pregabalin Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. Am J Kidney Dis. 2022 Jan;79(1):88-104

Beaulieu J, Roberts DM, Gosselin S, Hoffman RS, Lavergne V, Hovda KE, Megarbane B, Lung D, Thanacoody R, Ghannoum M. Treating ethylene glycol poisoning with alcohol dehydrogenase inhibition, but without extracorporeal treatments: a systematic review. Clinical Toxicology (Phila) 2022; 60(7): 784-797

Roberts DM, Hoffman RS, Brent J, Lavergne V, Hovda KE, Porter WH, McMartin KE, Ghannoum M. The serum glycolate concentration: its prognostic value and its correlation to surrogate markers in ethylene glycol exposures. Clinical Toxicology (Phila) 2022; 60(7):798-807

Murnion BP, Roberts DM. Responding to the rising number of suicides using barbiturates. Med J Aust. 2022; 216(4): 187-188.

Jamshidi N, Dhaliwal N, Hearn D, McCalman C, Wenzel R, Koutsogiannis Z, Roberts DM. Life-threatening barium carbonate poisoning managed with intravenous potassium, continuous veno-venous haemodialysis and endoscopic removal of retained ceramic glazes. Clin Toxicol (Phila). 2022 Aug;60(8):974-978.

Hlusicka J, Sevela S, Smid V, Sestak V, Roberts DM. Methaemoglobinaemia and oesophageal burns after accidental ingestion of an alkyl nitrite. Clin Toxicol (Phila). 2022; 60(11): 1288-1290.

Research letters/case/other reports

Chiew AL, Buckley NA. Comment on “The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes”. Clinical Toxicology 2022;60(9):1081-2. doi: 10.1080/15563650.2022.2101472

Chan BS, Buckley NA. Comment on – clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning Clinical Toxicology 2022; 60(4):448. doi: 10.1080/15563650.2021.2013497

Tan H, Stathakis P, Varghese B, Buckley NA, Chiew AL. Delayed Acetaminophen Absorption resulting in Acute Liver Failure. Case reports in Critical Care 2022; 2, Article ID 3672248, 6 pages. doi: 10.1155/2022/3672248

Chan BS, Buckley NA. Authors' reply to comment on: clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. Clinical Toxicology (Phila). 2022 Apr;60(4):548. doi: 10.1080/15563650.2021.2013497.

Rosenbaum E, Bode MJF, Roberts DM. Death from severe, refractory methaemoglobinaemia. A case report to illustrate an increasingly frequent manifestation of deliberate self-poisoning. Emerg Med Austral 2022; 34(4): 654-655.

Bode MJF, Huber J, Roberts DM. Decision-making in suicide: when is the patient not for resuscitation? Emerg Med Austral 2022; 34(3): 473-474. doi: 10.1111/1742-6723.13977. [case report]

Freeburn B, Lee K, Conigrave K. Patients from Aboriginal and Torres Strait Islander communities. In: NSW Ministry of Health. Management of withdrawal from alcohol and other drugs: Clinical Guidance. Sydney: NSW Ministry of Health; 2022. p. 90-2. www.health.nsw.gov.au/aod/professionals/Publications/clinical-guidance-withdrawal-alcohol-and-other-drugs.pdf

Freeburn B, Lee K, Conigrave K. Patients from Aboriginal and Torres Strait Islander communities. In: NSW Ministry of Health, editor. Management of Withdrawal from Alcohol and Other Drugs: Handbook. Sydney, NSW: NSW Ministry of Health; 2022. p. 46-8. www.health.nsw.gov.au/aod/professionals/Publications/handbook%20managing%20withdrawal%20alcohol%20and%20other%20drugs.pdf

Doyle MF, Perry J, Bower C, Conigrave K and Hamilton S. Fetal alcohol spectrum disorder and Aboriginal and Torres Strait Islander men: A discussion to be had. Drug and Alcohol Review 2023; 42(7):1601-1605. doi: 10.1111/dar.137

Finlay S, Doyle MF, Kennedy M. Aboriginal and Torres Strait Islander Human Ethics Committees (HRECs) are essential in promoting our health and wellbeing. Public Health Research & Practice 2023; 33(2). doi:10.17061/phrp3322312

Graham S, Martin K, Gardner K, Beadman M, Doyle MF, Bolt R, Murphy D, Newman C, Bell S, Treloar C, Browne AJ, Aggleton P, Beetson K, Brooks M, Botfield JR, Davis B, Wilms J, Leece B, Stanbury L, Bryant J. Aboriginal young people’s perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative study. Global Public Health 2023; 18(1). doi: 10.1080/17441692.2023.2196561

Liang Y, Roberts J, Conigrave K, Kim S, Doyle MF. Alcohol relapse prevention health care after alcohol withdrawal in New South Wales prisons, Australia: A patient file review. Drug and Alcohol Review 2023; 42(7): 1733-1743. doi:10.1111/dar.13741

Reid N, Kent N, Hewlett N, Bagley K, Tsang T, Goldsbury S, Williams R, Akison L, Holland L, Vanderpreet C, Doyle MF, Boaden N, Holland N. Factors to be considered as part of a holistic assessment for fetal alcohol spectrum disorder: A scoping review. Alcohol: Clinical and Experimental Research 2023; 47(11): 2007-2021.doi: 10.1111/acer.15191

Lee KSK, Conigrave JH, Wilson S, Perry J, Hayman N, Chikritzhs T, Room R, Weatherall TJ, Zheng C, Conigrave KM. Deeper understandings of patterns of drinking among Aboriginal and Torres Strait Islander Australians: informing policy and practice. Health Promotion Journal of Australia 2023; 34: 883-888.

Welch S, Moles R, Viardot A, Deweerd P, Daly S, Lee K. Connecting the Dots of Care: A pilot study linking Aboriginal and/or Torres Strait Islander peoples with diabetes care in hospital, using hospital pharmacists. Exploratory Research in Clinical and Social Pharmacy 2023; 12: 100351.

Conigrave JH, Devine EK, Lee KSK, Dobbins T, Vnuk J, Hayman N, Conigrave K. Unintended consequences: Alcohol screening at urban Aboriginal Community Controlled Health Services was suppressed during COVID-19 lockdowns. Drug and Alcohol Review 2023; 42(7): 1633-1638.

Mersha AG, Kennedy M, Eftekhari P, Lee KSK, Upton P, Segan C, Jackson M A, Jennings K, Gould GS. Using the Behaviour Change Wheel and modified Delphi method to identify behavioural change techniques for improving adherence to smoking cessation medications. BMC Public Health 2023; 23(1): 1362.

Tracy M, Freeburn B, Lee K, Woods J, Conigrave K. Review of alcohol and drug treatment for Aboriginal and Torres Strait Islander peoples. Journal of the Australian Indigenous HealthInfoNet 2023; 4(1).

Meharg DP, Naanyu V, Rambaldini B, Clarke MJ, Lacey C, Jebasingh F, Lopez-Jaramillo P, Gould GS, Aceves B, Alison JA, Chaiton M, Chen J, Gonzalez-Salazar F, Goodyear-Smith F, Gwynne KG, Lee KS, MacKay D, Maple-Brown L, Mishara BL, Nigenda G, Ramani-Chander A, Sherwood SG, Thomas N, Thrift AG, Anderson M. The Global Alliance for Chronic Diseases researchers’ statement on non-communicable disease research with Indigenous peoples. The Lancet Global Health 2023; 11(3): e324-e326.

Purcell-Khodr G, Conigrave JH, Lee KSK, Vnuk J, Conigrave KM. Low rates of prescribing alcohol relapse prevention medicines in Australian Aboriginal Community Controlled Health Services. Drug and Alcohol Review 2023; 42(7): 1606–1616.

Schölin L, Lee KSK, London L, Pearson M, Otieno F, Weerasinghe M, Konradsen F, Eddleston M, Sørensen JB. The role of alcohol use in pesticide suicide and self-harm: a scoping review. Social Psychiatry and Psychiatric Epidemiology 2023; 59(2): 211–232.

Pearson M, Dawson A, Raubenheimer J, Senerathna L, Conigrave K, Lee KSK, Rajapakse T, Pushpakumara PHGJ, Siribaddana S, Soerensen JB, Konradsen F, Jan S, Dawson AJ, Buckley N, Abeysinghe R, Siriwardhana P, Priyadarshana C, Haber PS, Dzidowska M, Abeykoon P, Glozier N. A community-based alcohol education intervention (THEATRE) study to reduce harmful effects of alcohol in rural Sri Lanka: Design and adaptation of a mixed-methods stepped wedge cluster randomised control trial. BMJ Open 2023; 13(6): e064722.

Marel C, Wilson J, Darke S, Ross J, Slade T, Haber PS, Haasnoot K, Visontay R, Keaveny M, Tremonti C, Mills KL, Teesson M. Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS). International journal of mental health and addiction 2023; 18:1-18. doi: 10.1007/s11469-022-01006-6. Epub ahead of print.

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. The Medical journal of Australia 2023; 218(3):138–139. Epub ahead of print.

Gardiner A, Volovets A, Haber P, Jo H, Visser S, Yozghatlian V, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T, Sivam D. ELX/TEZ/IVA use in cystic fibrosis liver disease: Is the perspective of improved lung function worth the risk?. J Cyst Fibros 2022; 21(5):881-884. doi: 10.1016/j.jcf.2022.06.008.

Logge WB, Morley KC, Haber PS, Baillie AJ. Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder. Neuropsychobiology 2023; 82(2):117-129. doi: 10.1159/000529156.

Logge W, Hurzeler T, Arunogiri S, Towers E, Baillie A, Haber PS, Morley K. Hypothalamic-pituitary-adrenocortical response in alcohol dependent patients during baclofen treatment and association with clinical outcome: preliminary results. Alcohol 2023; 112:25–29. doi: 10.1016/j.alcohol.2023.05.001.

Mason A, Riordan BC, Morley K, Winter T, Haber P, Scarf D. High Risk or Risky Highs: Understanding the Links Between Alcohol and Cannabis Use on the Transition From Suicidal Ideation to Attempts in Australian Men. Archives of suicide research 2024; 28(2), 600–609. doi.org/10.1080/13811118.2023.2199801.

Tremonti C, Teesson M, Marel C, Mills K, Haber PS. Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study. The Medical journal of Australia 2023; 219(5):227–229.

Morley KC, Peruch S, Adams C, Towers E, Tremonti C, Watt J, Jamshidi N, Haber PS. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial. Alcohol and alcoholism 2023; 58(5): 553–560. doi: 10.1093/alcalc/agad044.

Wilson J, Mills KL, Sunderland M, Freeman TP, Teesson M, Haber PS, Marel C. Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence. International journal of mental health and addiction 2023; 15:1-17. doi: 10.1007/s11469-023-01071-5. Epub ahead of print.

Wilson J, Mills K, Marel C, Freeman T, Haber P, Teesson M. The long-term relationship between cannabis and heroin use: An 18-20-year follow-up of the Australian Treatment Outcome Study (ATOS). American Journal of Psychiatry 2024; 181(2):135–143. doi.org/10.1176/appi.ajp.20230088

Wilson J, Mills KL, Sunderland M, Freeman TP, Keaveny M, Haasnoot K, Teesson M, Haber PS, Marel C. Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study. The International journal on drug policy 2023; 120:104187. doi: 10.1016/j.drugpo.2023.104187.

Higginbotham B, Perez JK, Louie E, Haber PS, Lubman D, Arunogiri S, Chatterton ML, Morley KC. Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder. The Australian and New Zealand journal of psychiatry 2024; 58(2):117-133. doi: 10.1177/00048674231201541.

Dali G, Logge W, Riordan B, Conner TS, Manning V, Millan EZ, McNally GP, Haber PS, Morley KC. The role of impulsivity in the relationship between affect and alcohol consumption in young adults. Alcohol Clin Exp Res (Hoboken) 2023; 47(11):2161-2168. doi: 10.1111/acer.15192.

Jackson MA, Brown AL, Baker AL, Bonevski B, Haber P, Bonomo Y, Blandthorn J, Attia J, Perry N, Barker D, Gould GS, Dunlop AJ. Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances: a feasibility trial. Front Psychiatry 2023 Aug 16; 14:1207955. doi: 10.3389/fpsyt.2023.1207955.

Adams C, Perry N, Conigrave J, Hurzeler T, Stevens J, Yacou Dunbar KP, Sweeney A, Lee K, Sutherland G, Haber P, Morley KC. Central markers of neuroinflammation in alcohol use disorder: A meta-analysis of neuroimaging, cerebral spinal fluid, and postmortem studies. Alcohol Clin Exp Res (Hoboken) 2023 Feb; 47(2):197-208. doi: 10.1111/acer.14992.

Grimison P, Mersiades A, Kirby A, Tognela A, Olver I, Morton RL, Haber P, Walsh A, Lee Y, Abdi E, Della-Fiorentina S, Aghmesheh M, Fox P, Briscoe K, Sanmugarajah J, Marx G, Kichenadasse G, Wheeler H, Chan M, Shannon J, Gedye C, Begbie S, Simes RJ, Stockler MR. Oral cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV): Final results of a randomized, placebo-controlled, phase 2/3 trial. Journal of Clinical Oncology. Accepted 18 Jan 2024.

Morley KC, Kranzler HR, Luquin N, Jamshidi N, Adams C, Montebello M, Tremonti C, Dali G, Logge W, Baillie A, Teesson M, Trent R, Haber PS. Topiramate versus naltrexone for alcohol use disorder: a genotype-stratified, double-blind randomised controlled trial. American Journal of Psychiatry 2024; 181(5):403–411. doi.org/10.1176/appi.ajp.20230666

Nash E, Dawson AH, Haber P, Gribble R, Volovets A. Substance use during hospitalisation requiring an urgent clinical response: an opportunity for intervention. Internal Medicine Journal 2024. doi.org/10.1111/imj.16336. Epub ahead of print.

Nash E, Liu K, Volovets A, Fitzpatrick M, Sullivan D, Khoo L and Haber P. Blood transfusion is a rare but potential source of false positive phosphatidylethanol. Liver Transplant 2024. doi.org/10.1097/LVT.0000000000000358. Epub ahead of print.

Bhardwaj AK, Mills L, Doyle M, Sahid A, Montebello M, Monds L, Arunogiri S, Haber P, Lorenzetti V, Lubman DI, Malouf P, Harrod ME, Dunlop A, Freeman T, Lintzeris N. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD‑CUD study protocol. BMC Psychiatry 2024. 24:175. doi.org/10.1186/s12888-024-05616-3.

Chiew A, Isbister GK, Chan BS, Isoardi K, Ress K, Stathakis P, Buckley NA. Acetaminophen metabolites on presentation following an acute acetaminophen overdose (ATOM-7). Clinical Pharmacology & Therapeutics 2023; 113(6):1304-14. doi:10.1002/cpt.2888.

Lim JS, Buckley NA, Cairns R, Schulman J, Schaffer AL, Chitty KM. Substances Detected During Coroner Postmortem Toxicology Analyses in Poisoning- and Nonpoisoning-Related Suicides. JAMA Psychiatry 2023; 80(11):1121-1130. doi:10.1001/jamapsychiatry.2023.2289

Chitty KM, Sperandei S, Carter G, Ali Z, Raubenheimer JE, Schaffer A, Page A, Buckley NA. Five healthcare trajectories in the year before suicide and what they tell us about opportunities for prevention: a population-level case series study. EClinical Medicine 2023; 63: 102165. doi: 10.1016/j.eclinm.2023.102165

Brett J, Gillies M, Buckley NA, Pearson SA, Zoega H. Patterns of sub-optimal antipsychotic use and misuse in Australia: What can routinely-collected data tell us? British Journal of Clinical Pharmacology 2023; 89(11):3411-3420. doi: 10.1111/bcp.15821

Chitty KM, Cvejic RC, Heintze T, Srasuebkul P, Morley K, Dawson A, Carter G, Dinh M, Buckley NA, Trollor JN. The Association Between Problematic Use of Alcohol and Drugs and Repeat Self-Harm and Suicidal Ideation: Insights From a Population-Based Administrative Health Data Set. Crisis: The Journal of Crisis Intervention and Suicide Prevention 2023; 44(4):309–317. doi:10.1027/0227-5910/a000880

Allaf S, Lim JS, Buckley NA, Cairns R. The Impact of Cannabis legalization and decriminalization on Acute Poisoning: A Systematic Review. Addiction 2023; 118:2252–2274. doi: 10.1111/add.16280.

Chitty KM, Buckley NA, Lim J, Ali Z, Schumann JL, Cairns R, Daniels B, Pearson SA, Preen D, Schaffer AL. Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data. Medical Journal of Australia 2023; 219(2):63-69. doi:10.5694/mja2.51985.

Cairns R, Noghrehchi F, Buckley NA. The impact on poisonings of up-scheduling of modified release paracetamol to Schedule 3 (pharmacist only medicine). Medical Journal of Australia 2023; 218(9):412-414. doi:10.5694/mja2.51888.

Noghrehchi F, Cairns R, Buckley NA. Hospital admissions for paracetamol poisoning declined following codeine re-scheduling in Australia. International Journal of Drug Policy 2023; 116:104040 doi:/10.1016/j.drugpo.2023.104040

Perananthan V, Wijerathna T, Mohamed F, Gawarammana IB, Dawson AH, Buckley NA. Measurement of an intestinal biomarker during poisonings from select toxicants and toxins. Clinical Toxicology 2023; 61(9):693-696. doi: 10.1080/15563650.2023.2265051.

Thurtle N, Kirby K, Greig J, Bil K, Ntadom G, Dargan PI, Buckley NA. Neonatal blood lead concentration predicts medium term lead-related outcomes in children ≤5 years old with congenital lead poisoning: a retrospective cohort study in Northern Nigeria. PLoS Global Public Health 2023; 3(3):e0001644. doi:10.1371/journal.pgph.0001644

Schaffer A, Gisev N, Degenhardt L, Blyth FM, Buckley NA, Currow D, Dobbins TA, Wilson A, Pearson SA. Opioid prescribing patterns among medical practitioners in New South Wales, Australia. Drug and Alcohol Review 2023; 42:1472–1481. doi: 10.1111/dar.13675.

de Oliveira Costa J, Lin J, Pearson SA, Buckley NA, Schaffer A, Falster M. Persistence and adherence to cardiovascular medicines in Australia. JAHA: Journal of the American Heart Association 2023; 12(13):e030264. doi:10.1161/JAHA.122.030264 IF:6.106

Cairns R, Buckley NA. Semaglutide exposures reported to the NSW Poisons Information Centre: effects of social media marketing and supply chain disruptions. Internal Medicine Journal 2023; 53: 654–655. doi:10.1111/imj.16059

Deuster E, Tomenson JA, Mohamed F, Gawarammana I, Buckley NA, Wilks MF, Eddleston M. Dose ingested, vomiting, and outcome in patients ingesting a standard paraquat 20SL formulation. Clinical Toxicology 2023; 61(1):29-38. doi: 10.1080/15563650.2022.2142601.

Jones CMP, Day RO, Koes BW, Latimer J, Maher CG, McLachlan AJ, Billot L, Shan S, Lin CC; OPAL Investigators Coordinators. Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial. Lancet 2023; 402(10398):304-312. doi: 10.1016/S0140-6736(23)00404-X.

Kim S, White B, Roberts J, Day C. Substance Use among Pregnant Women in NSW Prisons. The International journal on drug policy 2023 Dec; 122:104256. doi:10.1016/j.drugpo.2023.104256.

Little S, White B, Moensted M, Butler K, Howard M, Roberts J, Dunlop A. Health and correctional staff acceptability of depot buprenorphine in NSW prisons. The International journal on drug policy 2023 Apr; 114:103978. doi: 10.1016/j.drugpo.2023.103978.

Amir NA, Tangiisuran B, Samsudin S, Abd Rani NA, Fathelrahman AI, Mohamed F, Kamaruzaman NA. Trends in the Intentional and Non-intentional Poisoning-related Calls among Adolescents Reported to the Malaysia National Poison Centre (2010-2020). Universal Journal of Public Health 2023; 11(5):573-583. DOI: 10.13189/ujph.2023.110505

Mamunuwa N, Jayamanne S, Wijekoon N, Coombes J, Perera D, Shanika T, Mohamed F, Lynch C, De Silva A, Dawson A. Duplication errors due to brand name confusion; It's not always the name – Short case series. Clinical Case Reports 2023; 11:e7795. Doi. 10.1002/ccr3.7795

Bagyawantha NMY, Coombes ID, Gawarammana I, Mohamed F. Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol. BMJ Open 2023; 13:e059413. doi: 10.1136/bmjopen-2021-059413

Pandey DP, Shrestha BR, Acharya KP, Shah KJ, Thapa-Magar C, Dhakal IP, Mohamed F, Isbister GK. A prospective study of snakebite in a tertiary care hospital in south-western Nepal. Transactions of The Royal Society of Tropical Medicine and Hygiene 2023; 117(6), 435–443. doi.org/10.1093/trstmh/trac127

Qiang S, Mohamed F, Mackenzie L, Roberts MS. Rapid determination of polyethoxylated tallow amine surfactants in human plasma by LC-MSMS. Talanta 2022 Nov 19; 254:124115. doi: 10.1016/j.talanta.2022.124115.

Lee KSK, Wilson S, Stearne AE, Hayman N, Conigrave JH, Doyle M, Bullen L, Weatherall TJ, James D, Reynolds T, Perry J, Conigrave KM; Members, Investigators, Indigenous Advisory Group and staff of the Centre of Research Excellence in Indigenous Health and Alcohol. Walking side-by-side: Supporting Aboriginal and Torres Strait Islander Australians to lead the way in alcohol research. Drug Alcohol Rev. 2023 Feb;42(2):241-247. doi: 10.1111/dar.13523. Epub 2022 Aug 4. PMID: 35926891; PMCID: PMC10946518.

Lee KSK, Bullen LM, Zheng C, Dawson A, Munro A, Conigrave KM. Beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal clients to involuntary drug and alcohol treatment: A qualitative study. Drug Alcohol Rev. 2023 Jan;42(1):169-180. doi: 10.1111/dar.13549. Epub 2022 Oct 4. PMID: 36194535; PMCID: PMC10947027.

Sørensen JB, Lee KSK, Dawson A, Dawson A, Senarathna L, Pushpakumara PHGJ, Rajapakse T, Konradsen F, Glozier N, Conigrave KM, Siriwardhana P, Hansen D, Buhl A, Priyadhasana C, Senawirathna K, Herath M, Mantillake S, Fonseka P, Pearson M. Evaluating the programme and behavior change theories of a community alcohol education intervention in rural Sri Lanka: a study protocol. Glob Health Action. 2023 Dec 31;16(1):2273625. doi: 10.1080/16549716.2023.2273625. Epub 2023 Nov 16. PMID: 37971492; PMCID: PMC10795635.

Weatherall TJ, Conigrave JH, Lee KSK, Vnuk J, Ivers R, Hayman N, Wilson S, Gray D, Conigrave KM. Alcohol screening in 22 Australian Aboriginal Community Controlled Health Organisations: Clinical context and who is screened. Drug Alcohol Rev. in press 2023

Shihana F, Cholan PM, Fraser S, Oehlers SH, Seth D. Investigating the role of lipid genes in liver disease using fatty liver models of alcohol and high fat in zebrafish (Danio rerio). Liver Int. 2023 Nov;43(11):2455-2468. doi: 10.1111/liv.15716. Epub 2023 Aug 31. PMID: 37650211.

Shihana F, Joglekar MV, Schwantes-An TH, Hardikar AA, Seth D. MicroRNAs Signature Panel Identifies Heavy Drinkers with Alcohol-Associated Cirrhosis from Heavy Drinkers without Liver Injury. Biology (Basel). 2023 Oct 8;12(10):1314. doi: 10.3390/biology12101314. PMID: 37887024; PMCID: PMC10604848.

Uthurralt N, Ajwani S, Kiel R, Chandra S, Lama Rumba B, Day CA. Providing better access to oral health care for people receiving substance use treatment: A timely discussion. Drug Alcohol Rev. doi: 10.1111/dar.13753. Epub 2023 Sep 18. PMID: 37718615.

Monds, L.A., Singleton, M., & Russell, A.M.T. (2023). The Effects of Binge Drinking on Attention in Young Adults. Frontiers in Psychology, 14, 1147621; Preprinted in PsyArXiv psyarxiv.com/uentr

Monds, L.A., Topp, L., Pados, J., Holmes, J., & Lintzeris, N. (2023). The DACRIN Data Project: A process for harmonising data collection for clinical research in AOD services in NSW. Drug and Alcohol Review; Preprinted in PsyArXiv psyarxiv.com/rzym6

Russell, A.M.T., Monds, L., Hing, N., Kroll, J., Russell, A.M., & Thorne, H.B. (2023). Social associations and alcohol consumption in an Australian community sample: An egocentric social network analysis. Psychology of Addictive Behaviors; Preprinted in PsyArXiv osf.io/3nm6g

Monds, L.A., Crowe, A., Aguilera, M.B., Ridley, N., Newcombe, D., Mantell, R., Lintzeris, N., Withall, A. (2023). The feasibility of Goal Management Training to address cognitive impairment in an outpatient alcohol treatment population: findings from a novel case series. International Journal of Mental Health and Addiction; Preprinted in PsyArXiv psyarxiv.com/hka74

Martin, E., & Monds, L.A. (2023). The Effect of Victim Intoxication and Crime Type on Mock Jury Decision-Making. Psychology, Crime and Law; Preprinted in PsyArXiv osf.io/9csbu

Stevens, L., Monds, L.A., Riordan, B., Hayre, R. K., & Flowe, H.F. (2023). Acute alcohol intoxication and alcohol expectancy effects on women’s memory for consensual and non-consensual sexual activity. Frontiers in Psychology – Forensic and Legal Psychology.

Mantell, R., Withall, A., Radford, K., Kasumovic, M., Monds, L., Hwang, J. (2023). The design preferences for a Serious-Game-based cognitive assessment of older people in prison: Thematic analysis. JMIR Serious Games; Preprinted in JMIR Preprints. 02/01/2023:45467.

Grover, C., Monds, L.A., & Montebello, M. (2023). A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders. Australasian Psychiatry, 31(3), 329-335.

Sullivan, A., Ridley, N., Monds, L.A., Logge, W., Hurzeler, T., & Morley, K. (2023). Assessing the validity of the Wechsler Adult Intelligence Scale (WAIS-IV) in predicting completion in a long-term residential rehabilitation for substance use problems. Applied Neuropsychology: Adult; and Preprinted in PsyArXiv. https://doi.org/10.31234/osf.io/87rd5

Moensted ML, Little S, Haber PS, Day CA. (2024) Time to reconsider the best practice models of substance use care for young people. Drug and Alcohol Review. DOI: 10.1111/dar.13837

Makki A, Day CA, Chaar, B. Professional stigma towards clients with methamphetamine use disorder – A qualitative study. Journal of Pharmaceutical Policy and Practice. Accepted 10 January 2024.

Stirling R, Hudson S, Ross J, Deans E, Tibbetts J, Day C, Deacon R, Dunlop A, Nicholas Lintzeris N. Understanding the research capacity of alcohol and other drugs services in NSW, Australia. Drug and Alcohol Review. Accepted 23/10/23.

Uthurralt N, Cao FM, Burns L, Reid SE, Day CA. Characteristics of clients entering women-only substance use treatment services in New South Wales, Australia, 2014–2018. Women’s Health. Accepted 23/08/2023.

Roxburgh A, Livingston M, Dietze P, Nielsen S, Cogger S, Bartlett M, Day C, Latimer J, Jauncey M & Clark N. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia. Public Health. Accepted 15/08/2023.

Tae-Hwi Schwantes-An, John B. Whitfield, Guruprasad P. Aithal, Stephen R. Atkinson, Ramon Bataller, Greg Botwin, Naga P. Chalasani, Heather J. Cordell, Ann K. Daly, Rebecca Darlay Christopher P. Day, Florian Eyer, Tatiana Foroud, Samer Gawrieh, Dermot Gleeson, David Goldman, Paul S. Haber, Jean-Marc Jacquet, Craig S. Lammert, Tiebing Liang, Suthat Liangpunsakul, Steven Masson, Philippe Mathurin, Romain Moirand, Andrew McQuillin, Christophe Moreno, Marsha Y. Morgan, Sebastian Mueller, Beat Müllhaupt, Laura E. Nagy, Pierre Nahon, Bertrand Nalpas, Sylvie Naveau, Pascal Perney, Munir Pirmohamed, Helmut K. Seitz, Michael Soyka, Felix Stickel, Andrew Thompson, Mark R. Thursz, Eric Trépo, Timothy R. Morgan*, Devanshi Seth. A polygenic risk score for alcohol-related cirrhosis among heavy drinkers with European ancestry. Hepatol Comm 2023. doi:10.1097/hc9.0000000000000431

Graham, S., Blaxland, M., Bolt, R., Beadman, M., Gardner, K., Martin, K., Doyle, M., Beetson, K., Murphy, D., Bell, S., et al (2023). Aboriginal peoples' perspectives about COVID-19 vaccines and motivations to seek vaccination: a qualitative study. BMJ Global Health, 7(7), e008815. doi:10.1136/bmjgh-2022-008815

Perananthan V, Shihana F, Chiew AL, George J, Dawson AH, Buckley NA. Intestinal injury in paracetamol overdose (ATOM‐8). Journal of gastroenterology and Hepatology 2023. https://doi.org/10.1111/jgh.16450

Sutherland R, Man N, Brown J, Cairns R, Raubenheimer J, Grigg J, Dawson A, Jamshidi N, Peacock A. Has there been an increase in nitrous oxide use and associated harms in Australia? An analysis of triangulated data sources, 2003–2020. International Journal of Drug Policy. 2023 Nov 1;121:104178.

Schulz, Jennifer; Cimenti, Chiara; Priyadhasana, Chamil; Herath, Malith; Senerviratne, Kamal; Siribaddana, Sisira; Pushpakumara, PHGJ; Dawson, Andrew; Lee, Kylie; Konradsen, Flemming. The impact of early COVID-19 restrictions on alcohol consumption, intimate partner violence, and finances in rural Sri Lanka. Anuradhapura Medical Journal 17 1 2023 Anuradhapura Clinical Society

Shahmy, S., Kularatne, S.A.M., Gawarammana, I.B. et al. Compliance with national snakebite treatment guidelines in rural Sri Lankan hospitals: a cluster randomized controlled trial of a brief educational intervention. BMC Med Educ 23, 390 (2023). https://doi.org/10.1186/s12909-023-04375-1

Moxham R, Tjokrowidjaja A, Devery S, Smyth R, McLean A, Roberts D, Wu K. Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting. World Journal of Medical Genetics 2023; 2023; 11(4): 39-50

Moxham R, Tjokrowidjaja A, Devery S, Smyth R, McLean A, Roberts DM, Wu KHC. Clinical utilities and end-user experience of pharmacogenomics: 39 mo of clinical implementation experience in an Australian hospital setting. World J Med Genet 2023; 11(4): 39-50 [DOI: 10.5496/wjmg.v11.i4.39].

Penafiel R, Yoo D, Turner C, Brown JA, McDonald C, Tran J, Shaw V, Roberts DM. Toxicokinetics of thebaine in those consuming non-food grade poppy seeds as a tea. Clin Toxicol (Phila) 2023; 61(9): 644-648.

Stefani M, Musgrave K, Sevastos J, Penny M, Day RO, Roberts DM. Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing software. Nephrology (Carlton) 2023; 28(10): 534-539.

Yang JJ, Brett J, Sordo A, Reuter SE, Stocker SL, Day RO, Roberts DM, Carland JE. The influence of a therapeutic drug monitoring service on vancomycin associated nephrotoxicity. J Clin Pharmacol 2023; In press.

Isoardi KZ, Roberts DM, Holford AG, Brown JA, Griffiths A, Soderstrom J, McDonald C, Gerostamoulos D, Sakraja P, Turner C, Yates H, Gunja N, Greene S. A cluster of acute thebaine poisonings from non-food grade poppy seeds in the Australian food supply. Clin Toxicol (Phila) 2023; 61(9): 639-643.

Freestone Jack, Ezard N, Bourne A, Brett J, Roberts DM, Hammoud M, Nedanoski A, Prestage G, Siefried KJ. Understandings, attitudes, practices and responses to GHB overdose among GHB consumers. Harm Reduction Journal 2023, 2023; 20(1): 121.

Siefried KJ, Freeman G, Roberts DM, Lindsey T, Rodgers C, Ezard N, Brett J. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology 2023; 240(1): 127-135.

Rafizadeh A, Kolahi AA, Shariati S, Zamani N, Roberts DM, Hassanian-Moghaddam H. The danger of the toxicity and inefficacy of alcohol-based hand rubs in Iran during COVID-19: a cross-sectional study. Antimicrob Resist Infect Control 2023; 12(1): 42.

Freeman G, Siefried K, Roberts DM, Rodgers C, Nic Ionmhain U, Ramanathan Jay, Ezard N, Brett J. Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: a case series. Drug and Alcohol Review 2023; 42(1): 27-32.

Chakar B, Salter M, Roberts DM. Minoxidil overdose with hypotension effectively managed with norepinephrine, rather than dopamine. Clin Toxicol (Phila). 2023 Feb;61(2):133-134.

White A, Seah V, Brown J, McDonald C, Tran J, Roberts DM. Acute metonitazene poisoning reversed by naloxone. Clin Toxicol (Phila). 2023 Feb;61(2):137-138

Chidiac A, Buckley NA, Noghrehchi F, Cairns R. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opinion on Drug Metabolism and Toxicology 2023;19(5):297-317. doi: 10.1080/17425255.2023.2223959.

Guajardo MGU, Mukumbang FC, Moore C, Jones T, Woolfenden S, Ostojic K, Haber P, Eastwood J, Gillespie J, Schneider CH. How can we define social care and what are the levels of true integration in integrated care? A narrative review. Journal of Integrated Care 2023; 31(5): 43–84. doi.org/10.1108/jica-08-2022-0045.

Ghannoum M, Gosselin S, Hoffman RS, Lavergne V, Mégarbane B, Hassanian-Moghaddam H, Rif M, Kallab S, Bird S, Wood DM, Roberts DM; EXTRIP workgroup. Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup. Critical Care 2023 Feb 10;27(1):56.

Roberts DM, Beaulieu J. Metabolic complications of poisoning. Medicine 2023; In press.

Roberts DM, Ghannoum M. Expanding the evidence for managing metformin poisoning to improve decision-making. Clin Toxicol (Phila) 2023; 61(4): 203-206.

Ghannoum M, Roberts DM. Management of poisonings and intoxications. Clin J Am Soc Nephrol. 2023; 18(9): 1210-1221

Chiew AL, Buckley NA. Comment on “Population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations”. Clinical Toxicology 2023;61(2):139-140. doi: 10.1080/15563650.2022.2135519

Logge, W…Morley, K.C. (2023) Hypothalamic-pituitary-adrenocortical response in alcohol patients during baclofen treatment and association with clinical outcome: preliminary results. Alcohol, in press

Mason, A., Riordan, B., Morley, K.C. (2023) High Risk or Risky Highs: Understanding the Links Between Alcohol and Cannabis Use on the Transition From Suicidal Ideation to Attempts in Australian Men Archives of Suicidal Research, in press

Adams, C…Morley, K.C (2023). Central markers of neuroinflammation in alcohol use disorder: A systematic review of neuroimaging, cerebral spinal fluid and post-mortem studies. Alcoholism: Clinical and Experimental Research 47(2):197-208

Logge,W, Morley, K.C, Baillie, A. (2023). Impaired decision-making and skin conductance responses are associated with reward and punishment sensitivity in alcohol use disorder individuals. Neurophysiology, 1-13.

Louie, E… Haber, P, Morley, K.C (2023) Geographical variation in implementation of the Pathways to Comorbidity Care (PCC) program in Australian drug and alcohol services. JBI Evidence Implementation, in press

Logge, W. Morley, K. (2023). Sex differences in the interrelations between stress, craving and alcohol consumption across individuals and time during baclofen treatment for alcohol dependence, Addictive Behaviors, 107462 10.1016/j.addbeh.2022.107462

Chidiac AS, Buckley NA, Noghrehchi F, Cairns R. Paracetamol Dosing Errors in People Aged 12 Years and Over: An Analysis of Over 14,000 Cases Reported to an Australian Poisons Information Centre. Drug Saf. 2024 Dec;47(12):1293-1306. doi: 10.1007/s40264-024-01472-y. Epub 2024 Sep 2. PMID: 39222216; PMCID: PMC11554734.

Buckley NA, Noghrehchi F, Elliott RA, Wylie C, Merwood N, Benger L, Brown J, Cairns R. Self-poisoning in young Australians: The impact of COVID-19 and recent trends following easing of restrictions. Aust N Z J Psychiatry. 2024 Nov 18:48674241291321. doi: 10.1177/00048674241291321. Epub ahead of print. PMID: 39552223.

Smit K, Rintala J, Riordan B, Lee K, Laslett AM. Parental alcohol use and the level of child protection response in Australia (2012-21). Addiction. 2024 Nov 18. doi: 10.1111/add.16677. Epub ahead of print. PMID: 39558207.

Hurzeler TP, Logge W, Watt J, DeMayo MM, Suraev A, McGregor IS, Haber PS, Morley KC. The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial. Contemp Clin Trials Commun. 2024 Aug 13;41:101341. doi: 10.1016/j.conctc.2024.101341. PMID: 39252861; PMCID: PMC11382041.

Logge WB, Haber PS, Hurzeler TP, Towers EE, Morley KC. The effects of N-acetyl cysteine on intrinsic functional connectivity and neural alcohol cue reactivity in treatment-seeking individuals with alcohol use disorder: a preliminary study. Psychopharmacology (Berl). 2024 Aug 5. doi: 10.1007/s00213-024-06656-z. Epub ahead of print. PMID: 39102049.

Conigrave JH, Lee KSK, Dobbins T, Wilson S, Padarian J, Ivers R, Morley K, Haber PS, Vnuk J, Marshall K, Conigrave K. No improvement in AUDIT-C screening and brief intervention rates among wait-list controls following support of Aboriginal Community Controlled Health Services: evidence from a cluster randomised trial. BMC Health Serv Res. 2024 Jul 15;24(1):813. doi: 10.1186/s12913-024-11214-6. PMID: 39010081; PMCID: PMC11247787.

Schwantes-An TH, Whitfield JB, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Darlay R, Day CP, Eyer F, Foroud T, Gawrieh S, Gleeson D, Goldman D, Haber PS, Jacquet JM, Lammert CS, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D; GenomALC Consortium. A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry. Hepatol Commun. 2024 May 10;8(6):e0431. doi: 10.1097/HC9.0000000000000431. PMID: 38727677; PMCID: PMC11093576.

Morley KC, Kranzler HR, Luquin N, Jamshidi N, Adams C, Montebello M, Tremonti C, Dali G, Logge W, Baillie A, Teesson M, Trent R, Haber PS. Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial. Am J Psychiatry. 2024 May 1;181(5):403-411. doi: 10.1176/appi.ajp.20230666. PMID: 38706338

Stirling R, Hudson S, Ross J, Deans E, Tibbetts J, Day C, Deacon R, Dunlop A, Lintzeris N. Understanding the research capacity of alcohol and other drugs services in New South Wales, Australia. Drug Alcohol Rev. 2024 Jan;43(1):265-277. doi: 10.1111/dar.13776. Epub 2023 Nov 27. PMID: 38009912

Dzidowska M, Lee KSK, Conigrave JH, Wilson S, Hayman N, Ivers R, Vnuk J, Haber P, Conigrave KM. Supporting alcohol brief interventions and pharmacotherapy provision in Australian First Nations primary care: exploratory analysis of a cluster randomised trial. BMC Prim Care. 2024 Sep 28;25(1):351. doi: 10.1186/s12875-024-02598-9. PMID: 39342107; PMCID: PMC11438139.

Nash E, Dawson AH, Haber P, Gribble R, Volovets A. Substance use during hospitalisation requiring an urgent clinical response: an opportunity for intervention. Intern Med J. 2024 Jun;54(6):925-931. doi: 10.1111/imj.16336. Epub 2024 Jan 23. PMID: 38263859.

Cairns R, Noghrehchi F, Raubenheimer JE, Chitty KM, Isbister GK, Chiew AL, Brett J, Dawson AH, Brown JA, Buckley NA. Poisoning and envenomation linkage to evaluate outcomes and clinical variation in Australia (PAVLOVA): a longitudinal data-linkage cohort of acute poisonings, envenomations, and adverse drug reactions in New South Wales, Australia, 2011-2020. Clin Toxicol (Phila). 2024 Oct;62(10):615-624. doi: 10.1080/15563650.2024.2398119. Epub 2024 Oct 1. Erratum in: Clin Toxicol (Phila). 2024 Oct 10:1-2. doi: 10.1080/15563650.2024.2415238. PMID: 39350754.

Bhardwaj AK, Mills L, Doyle M, Sahid A, Montebello M, Monds L, Arunogiri S, Haber P, Lorenzetti V, Lubman DI, Malouf P, Harrod ME, Dunlop A, Freeman T, Lintzeris N. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC Psychiatry. 2024 Mar 4;24(1):175. doi: 10.1186/s12888-024-05616-3. PMID: 38433233; PMCID: PMC10910760.

Higginbotham B, Perez JK, Louie E, Haber PS, Lubman D, Arunogiri S, Chatterton ML, Morley KC. Economic evaluations of alcohol pharmacotherapy: Systematic review of economic evaluations of pharmacotherapy for the treatment of alcohol use disorder. Aust N Z J Psychiatry. 2024 Feb;58(2):117-133. doi: 10.1177/00048674231201541. Epub 2023 Oct 12. PMID: 37822267; PMCID: PMC10838482.

Uthurralt N, Ajwani S, Kiel R, Chandra S, Lama Rumba B, Day CA. Providing better access to oral health care for people receiving substance use treatment: A timely discussion. Drug Alcohol Rev. 2024 Jan;43(1):257-260. doi: 10.1111/dar.13753. Epub 2023 Sep 18. PMID: 37718615.

Hocknull K, Geiger B, Bartlett M, Colledge-Frisby S, Shand F, Day CA, Jauncey M, Roxburgh A. Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney. Drug Alcohol Rev. 2024 Sep;43(6):1597-1606. doi: 10.1111/dar.13900. Epub 2024 Jul 9. PMID: 38982725.

Mason A, Riordan BC, Morley K, Winter T, Haber P, Scarf D. High Risk or Risky Highs: Understanding the Links Between Alcohol and Cannabis Use on the Transition From Suicidal Ideation to Attempts in Australian Men. Arch Suicide Res. 2024 Apr-Jun;28(2):600-609. doi: 10.1080/13811118.2023.2199801. Epub 2023 May 7. PMID: 37151101.

Lawson S, Bryant J, Freund M, Dizon J, Haber PS, Shakeshaft A, Jefferies M, Farrell M. Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse. Drug Alcohol Rev. 2024 Jul;43(5):1194-1203. doi: 10.1111/dar.13833. Epub 2024 Mar 10. PMID: 38462541.

Makki A, Day C, Chaar BB. Professional stigma towards clients with methamphetamine use disorder - a qualitative study. J Pharm Policy Pract. 2024 Mar 6;17(1):2306869. doi: 10.1080/20523211.2024.2306869. PMID: 38456180; PMCID: PMC10919299.

Tremonti C, Celemajer DS, Marel C, Mills K, Foo S, Wilson J, Slade T, Teesson M, Haber P. Low Risk of Cardiac Complications During Long-Term Follow-Up of Opioid Dependence. J Addict Med. 2024 Sep-Oct 01;18(5):526-532. doi: 10.1097/ADM.0000000000001317. Epub 2024 Jun 5. PMID: 38941157.

Camacho X, Schaffer AL, Brett J, Pratt N, Buckley NA, Henry D, Pearson SA. Quality use of publicly subsidised tapentadol in Australia: a population-based analysis. Intern Med J. 2024 Jun;54(6):941-950. doi: 10.1111/imj.16335. Epub 2024 Feb 1. PMID: 38299430

Bryant J, Bolt R, Martin K, Beadman M, Doyle M, Treloar C, Bell S, Murphy D, Newman C, Browne A, Aggleton P, Beetson K, Brooks M, Wilms J, Leece B, Stanbury L, Botfield J, Davis B, Graham S. Yarning as a method for building sexual wellbeing among urban Aboriginal young people in Australia. Cult Health Sex. 2024 Jul;26(7):871-886. doi: 10.1080/13691058.2023.2258948. Epub 2023 Sep 23. PMID: 37740584.

Chakar B, Kabir S, Dane C, Proschogo N, Dawson A. Paramao root oil: a novel culprit in salicylate poisoning. Clin Toxicol (Phila). 2024 Mar;62(3):202-203. doi: 10.1080/15563650.2024.2329347. Epub 2024 Apr 5. PMID: 38577862.

Wilson J, Mills KL, Sunderland M, Freeman TP, Teesson M, Haber PS, Marel C. The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS). Am J Psychiatry. 2024 Feb 1;181(2):135-143. doi: 10.1176/appi.ajp.20230088. Epub 2023 Nov 29. PMID: 38018142.

Gibbs D, Colledge-Frisby S, Farnbach S, Doyle M, Shakeshaft A, Larney S. Associations Between Supported Accommodation and Health and Re-offending Outcomes: a Retrospective Data Linkage Study. J Urban Health. 2024 Feb;101(1):80-91. doi: 10.1007/s11524-023-00824-w. Epub 2024 Feb 13. PMID: 38349583; PMCID: PMC10897077.

Radha Krishnan RP, Harrison C, Buckley N, Raubenheimer JE. On- and off-label utilisation of antipsychotics in Australia (2000-2021): Retrospective analysis of two medication datasets. Aust N Z J Psychiatry. 2024 Apr;58(4):320-333. doi: 10.1177/00048674231210209. Epub 2023 Nov 9. PMID: 37941354; PMCID: PMC10960313.

Grimison P, Mersiades A, Kirby A, Tognela A, Olver I, Morton RL, Haber P, Walsh A, Lee Y, Abdi E, Della-Fiorentina S, Aghmesheh M, Fox P, Briscoe K, Sanmugarajah J, Marx G, Kichenadasse G, Wheeler H, Chan M, Shannon J, Gedye C, Begbie S, Simes RJ, Stockler MR. Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. J Clin Oncol. 2024 Aug 16:JCO2301836. doi: 10.1200/JCO.23.01836. Epub ahead of print. PMID: 39151115.

Moensted ML, Little S, Haber P, Day C. Time to reconsider the best practice models of substance use care for young people. Drug Alcohol Rev. 2024 May;43(4):817-822. doi: 10.1111/dar.13837. Epub 2024 Mar 21. PMID: 38511406.